Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:tetraphene
go back to main search page
Accession:CHEBI:51348 term browser browse the term
Definition:An angular ortho-fused polycyclic arene consisting of four fused benzene rings.
Synonyms:related_synonym: 1,2-Benzanthracene;   1,2-Benzanthrazen;   2,3-benzphenanthrene;   Benz[a]anthracene;   Formula=C18H12;   InChI=1S/C18H12/c1-2-7-15-12-18-16(11-14(15)6-1)10-9-13-5-3-4-8-17(13)18/h1-12H;   InChIKey=DXBHBZVCASKNBY-UHFFFAOYSA-N;   SMILES=c1ccc2cc3c(ccc4ccccc34)cc2c1;   benzanthrene;   naphthanthracene
 alt_id: CHEBI:33088;   CHEBI:34557
 xref: Beilstein:1909298;   CAS:56-55-3;   Gmelin:244702;   KEGG:C14317
 xref_mesh: MESH:C030935
 xref: PMID:25528193;   PMID:25528488;   PMID:26720419;   PMID:7561049;   Patent:DE481819;   Patent:DE486766;   Reaxys:1909298;   Wikipedia:Tetraphene



show annotations for term's descendants           Sort by:
tetraphene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1cf APOBEC1 complementation factor decreases expression ISO benz(a)anthracene results in decreased expression of A1CF mRNA CTD PMID:26377693 NCBI chr 1:229,736,037...229,823,499 JBrowse link
G Aaas aladin WD repeat nucleoporin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AAAS mRNA CTD PMID:27858113 NCBI chr 7:133,464,315...133,483,961 JBrowse link
G Aasdh aminoadipate-semialdehyde dehydrogenase affects expression ISO benz(a)anthracene affects the expression of AASDH mRNA CTD PMID:26377693 NCBI chr14:31,255,019...31,281,802 JBrowse link
G Aatk apoptosis-associated tyrosine kinase increases expression ISO benz(a)anthracene results in increased expression of AATK mRNA CTD PMID:26377693 NCBI chr10:105,789,171...105,825,634 JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression ISO benz(a)anthracene results in increased expression of ABCC3 mRNA CTD PMID:26377693 NCBI chr10:79,793,571...79,839,528 JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ABCC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABCC5 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr11:93,975,579...94,071,659 JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 decreases expression ISO benz(a)anthracene results in decreased expression of ABCC9 mRNA CTD PMID:26377693 NCBI chr 4:177,262,848...177,386,837 JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression ISO benz(a)anthracene results in increased expression of ABHD15 mRNA CTD PMID:26377693 NCBI chr10:62,363,209...62,368,600 JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO benz(a)anthracene results in increased expression of ABHD6 mRNA CTD PMID:26377693 NCBI chr15:16,859,740...16,907,094 JBrowse link
G Abi3bp ABI family member 3 binding protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 NCBI chr11:43,912,187...44,128,888 JBrowse link
G Ablim1 actin-binding LIM protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ABLIM1 mRNA CTD PMID:27858113 NCBI chr 1:266,088,868...266,377,169 JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ABRAXAS2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABRAXAS2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:187,647,078...187,672,660 JBrowse link
G Accs 1-aminocyclopropane-1-carboxylate synthase increases expression ISO benz(a)anthracene results in increased expression of ACCS mRNA CTD PMID:26377693 NCBI chr 3:79,805,254...79,820,830 JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ACIN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACIN1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr15:32,072,121...32,117,004 JBrowse link
G Acot1 acyl-CoA thioesterase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOT1 mRNA CTD PMID:27858113 NCBI chr 6:103,636,173...103,644,167 JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of ACOX1 mRNA; benz(a)anthracene results in increased expression of ACOX1 protein
benz(a)anthracene promotes the reaction [[ACOX1 protein results in increased metabolism of Palmitoyl Coenzyme A] which results in increased chemical synthesis of Hydrogen Peroxide]
CTD PMID:10497882 NCBI chr10:101,905,083...101,930,136 JBrowse link
G Acoxl acyl-CoA oxidase-like decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ACOXL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOXL mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:115,061,069...115,367,032 JBrowse link
G Acrbp acrosin binding protein affects expression ISO benz(a)anthracene affects the expression of ACRBP mRNA CTD PMID:26377693 NCBI chr 4:157,851,149...157,864,211 JBrowse link
G Acvr1b activin A receptor type 1B increases expression ISO benz(a)anthracene results in increased expression of ACVR1B mRNA CTD PMID:26377693 NCBI chr 7:134,164,987...134,208,389 JBrowse link
G Adam22 ADAM metallopeptidase domain 22 increases expression ISO benz(a)anthracene results in increased expression of ADAM22 mRNA CTD PMID:26377693 NCBI chr 4:25,716,055...25,970,932 JBrowse link
G Adamdec1 ADAM-like, decysin 1 increases expression ISO benz(a)anthracene results in increased expression of ADAMDEC1 mRNA CTD PMID:26377693 NCBI chr15:42,900,629...42,921,684 JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif, 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADAMTS14 mRNA CTD PMID:27858113 NCBI chr20:29,143,029...29,219,846 JBrowse link
G Adcy7 adenylate cyclase 7 increases expression ISO benz(a)anthracene results in increased expression of ADCY7 mRNA CTD PMID:26377693 NCBI chr19:34,913,154...34,972,366 JBrowse link
G Add3 adducin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA CTD PMID:27858113 NCBI chr 1:262,152,722...262,260,504 JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 increases expression ISO benz(a)anthracene results in increased expression of ADGRE4 mRNA CTD PMID:26377693 NCBI chr 9:9,758,106...9,901,908 JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADGRL4 mRNA CTD PMID:27858113 NCBI chr 2:240,354,909...240,457,231 JBrowse link
G Adm adrenomedullin decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ADM mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADM mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:174,164,178...174,182,372 JBrowse link
G Adora1 adenosine A1 receptor increases expression ISO benz(a)anthracene results in increased expression of ADORA1 mRNA CTD PMID:26377693 NCBI chr13:45,658,872...45,695,821 JBrowse link
G Adra1b adrenoceptor alpha 1B decreases expression ISO benz(a)anthracene results in decreased expression of ADRA1B mRNA CTD PMID:26377693 NCBI chr10:28,255,025...28,373,418 JBrowse link
G Adrb3 adrenoceptor beta 3 affects expression ISO benz(a)anthracene affects the expression of ADRB3 mRNA CTD PMID:26377693 NCBI chr16:64,839,820...64,844,552 JBrowse link
G Aen apoptosis enhancing nuclease multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA CTD PMID:27858113 NCBI chr 1:132,815,094...132,824,522 JBrowse link
G Agbl2 AGBL carboxypeptidase 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of AGBL2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:76,764,893...76,800,071 JBrowse link
G Ago2 argonaute RISC catalytic component 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA CTD PMID:27858113 NCBI chr 7:106,907,209...106,994,124 JBrowse link
G Ago4 argonaute RISC component 4 decreases expression ISO benz(a)anthracene results in decreased expression of AGO4 mRNA CTD PMID:26377693 NCBI chr 5:138,780,446...138,825,898 JBrowse link
G Agrp agouti related neuropeptide increases expression ISO benz(a)anthracene results in increased expression of AGRP mRNA CTD PMID:26377693 NCBI chr19:33,447,992...33,481,602 JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO benz(a)anthracene results in increased expression of AGTR1A mRNA CTD PMID:26377693 NCBI chr17:34,383,397...34,435,523 JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHCYL2 mRNA CTD PMID:27858113 NCBI chr 4:58,381,290...58,531,061 JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of AHNAK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHNAK mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:205,882,225...205,970,934 JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 decreases expression ISO benz(a)anthracene results in decreased expression of AHNAK2 mRNA CTD PMID:26377693 NCBI chr 6:131,830,668...131,876,311 JBrowse link
G Ahr aryl hydrocarbon receptor affects response to substance
increases activity
increases response to substance
multiple interactions
affects binding
ISO
EXP
AHR affects the susceptibility to benz(a)anthracene
benz(a)anthracene results in increased activity of AHR protein
AHR results in increased susceptibility to benz(a)anthracene
[benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with TNF protein] results in increased activity of AHR protein; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; AHR protein affects the reaction [[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6]; AHR protein affects the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]; AHR protein promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; benz(a)anthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]
benz(a)anthracene binds to AHR protein
AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]]; benz(a)anthracene binds to and results in increased activity of AHR protein; benz(a)anthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
AHR affects the reaction [benz(a)anthracene results in increased expression of CCNA2 protein]; AHR affects the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; benz(a)anthracene binds to and results in increased activity of AHR protein; benz(a)anthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
CTD PMID:1650214 PMID:1654865 PMID:1658612 PMID:2154949 PMID:3005314 More... NCBI chr 6:57,961,423...57,998,901 JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of AHRR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AHRR mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:28,993,634...29,088,673 JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AIF1 mRNA CTD PMID:27858113 NCBI chr20:3,651,435...3,657,341 JBrowse link
G Aifm3 AIF family member 3 increases expression ISO benz(a)anthracene results in increased expression of AIFM3 mRNA CTD PMID:26377693 NCBI chr11:83,504,859...83,523,630 JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO benz(a)anthracene results in decreased expression of AKAP13 mRNA CTD PMID:26377693 NCBI chr 1:129,313,183...129,619,647 JBrowse link
G Akap7 A-kinase anchoring protein 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA CTD PMID:27858113 NCBI chr 1:21,906,503...22,168,663 JBrowse link
G Akap8 A-kinase anchoring protein 8 increases expression ISO benz(a)anthracene results in increased expression of AKAP8 mRNA CTD PMID:26377693 NCBI chr 7:11,316,224...11,332,523 JBrowse link
G Akap8l A-kinase anchoring protein 8 like increases expression ISO benz(a)anthracene results in increased expression of AKAP8L mRNA CTD PMID:26377693 NCBI chr 7:11,332,671...11,362,287 JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO benz(a)anthracene results in increased expression of AKR1B10 mRNA CTD PMID:22236718 NCBI chr 4:64,005,632...64,027,860 JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression ISO benz(a)anthracene results in increased expression of AKR1C1 mRNA CTD PMID:17253728 PMID:22236718 NCBI chr17:70,720,397...70,747,285 JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression ISO benz(a)anthracene results in increased expression of AKR1C3 mRNA CTD PMID:22236718 NCBI chr17:71,020,884...71,037,779 JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 decreases expression ISO benz(a)anthracene results in decreased expression of ALDH1L1 mRNA CTD PMID:26377693 NCBI chr 4:123,059,989...123,106,471 JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression ISO benz(a)anthracene results in increased expression of ALDH3A1 mRNA CTD PMID:32890658 NCBI chr10:46,392,464...46,402,151 JBrowse link
G Alg6 ALG6, alpha-1,3-glucosyltransferase increases expression ISO benz(a)anthracene results in increased expression of ALG6 mRNA CTD PMID:26377693 NCBI chr 5:119,520,415...119,606,365 JBrowse link
G Alkal1 ALK and LTK ligand 1 increases expression ISO benz(a)anthracene results in increased expression of ALKAL1 mRNA CTD PMID:26377693 NCBI chr 5:13,019,729...13,049,913 JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO benz(a)anthracene results in increased expression of ALOX12 mRNA CTD PMID:26377693 NCBI chr10:54,958,263...54,970,542 JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO benz(a)anthracene results in increased expression of ALOX5 mRNA CTD PMID:26377693 NCBI chr 4:151,203,948...151,251,126 JBrowse link
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO benz(a)anthracene results in increased expression of ALPL mRNA CTD PMID:26377693 NCBI chr 5:155,234,770...155,289,785 JBrowse link
G Als2cl ALS2 C-terminal like affects expression ISO benz(a)anthracene affects the expression of ALS2CL mRNA CTD PMID:26377693 NCBI chr 8:110,863,753...110,884,434 JBrowse link
G Amdhd2 amidohydrolase domain containing 2 increases expression ISO benz(a)anthracene results in increased expression of AMDHD2 mRNA CTD PMID:26377693 NCBI chr10:13,187,579...13,196,148 JBrowse link
G Angpt2 angiopoietin 2 increases expression ISO benz(a)anthracene results in increased expression of ANGPT2 mRNA CTD PMID:26377693 NCBI chr16:71,088,364...71,138,805 JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANGPTL4 mRNA CTD PMID:27858113 NCBI chr 7:14,550,288...14,557,797 JBrowse link
G Ank3 ankyrin 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA CTD PMID:27858113 NCBI chr20:18,602,267...19,225,831 JBrowse link
G Ankrd12 ankyrin repeat domain 12 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANKRD12 mRNA CTD PMID:27858113 NCBI chr 9:105,583,273...105,687,957 JBrowse link
G Ankrd16 ankyrin repeat domain 16 affects expression ISO benz(a)anthracene affects the expression of ANKRD16 mRNA CTD PMID:26377693 NCBI chr17:66,735,325...66,748,533 JBrowse link
G Ankzf1 ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 increases expression ISO benz(a)anthracene results in increased expression of ANKZF1 mRNA CTD PMID:26377693 NCBI chr 9:76,688,194...76,695,162 JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A increases expression ISO benz(a)anthracene results in increased expression of ANP32A mRNA CTD PMID:26377693 NCBI chr 8:62,829,099...62,865,443 JBrowse link
G Anpep alanyl aminopeptidase, membrane multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANPEP mRNA CTD PMID:27858113 NCBI chr 1:143,176,645...143,219,447 JBrowse link
G Anxa10 annexin A10 increases expression ISO benz(a)anthracene results in increased expression of ANXA10 mRNA CTD PMID:26377693 NCBI chr16:27,738,712...27,805,648 JBrowse link
G Ap5s1 adaptor related protein complex 5 subunit sigma 1 increases expression ISO benz(a)anthracene results in increased expression of AP5S1 mRNA CTD PMID:26377693 NCBI chr 3:118,429,618...118,432,929 JBrowse link
G Ap5z1 adaptor related protein complex 5 subunit zeta 1 affects expression ISO benz(a)anthracene affects the expression of AP5Z1 mRNA CTD PMID:26377693 NCBI chr12:12,093,834...12,109,043 JBrowse link
G Apbb3 amyloid beta precursor protein binding family B member 3 affects expression ISO benz(a)anthracene affects the expression of APBB3 mRNA CTD PMID:26377693 NCBI chr18:28,547,205...28,554,383 JBrowse link
G Apobec3 apolipoprotein B mRNA editing enzyme catalytic subunit 3 increases expression ISO benz(a)anthracene results in increased expression of APOBEC3 mRNA CTD PMID:26377693 NCBI chr 7:111,433,789...111,453,032 JBrowse link
G Apol9a apolipoprotein L9a decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of APOL9A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of APOL9A mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 7:109,140,871...109,149,799 JBrowse link
G Appl2 adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 increases expression ISO benz(a)anthracene results in increased expression of APPL2 mRNA CTD PMID:26377693 NCBI chr 7:20,135,248...20,184,757 JBrowse link
G Aqp4 aquaporin 4 decreases expression ISO benz(a)anthracene results in decreased expression of AQP4 mRNA CTD PMID:26377693 NCBI chr18:6,782,389...6,799,034 JBrowse link
G Ar androgen receptor increases activity
multiple interactions
EXP
ISO
benz(a)anthracene results in increased activity of AR protein
benz(a)anthracene binds to and results in decreased activity of AR protein; benz(a)anthracene inhibits the reaction [Androgens results in increased activity of AR protein]
CTD PMID:10771140 PMID:28377212 NCBI chr  X:63,104,771...63,273,934 JBrowse link
G Arap2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 decreases expression ISO benz(a)anthracene results in decreased expression of ARAP2 mRNA CTD PMID:26377693 NCBI chr14:50,921,323...51,120,972 JBrowse link
G Areg amphiregulin increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of AREG mRNA
bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of AREG mRNA]]; Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of AREG mRNA]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AREG mRNA
CTD PMID:22643241 PMID:27858113 NCBI chr14:17,256,384...17,265,641 JBrowse link
G Arglu1 arginine and glutamate rich 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ARGLU1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARGLU1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr16:87,455,097...87,479,148 JBrowse link
G Arhgap20 Rho GTPase activating protein 20 decreases expression ISO benz(a)anthracene results in decreased expression of ARHGAP20 mRNA CTD PMID:26377693 NCBI chr 8:52,074,472...52,155,739 JBrowse link
G Arhgap23 Rho GTPase activating protein 23 decreases expression ISO benz(a)anthracene results in decreased expression of ARHGAP23 mRNA CTD PMID:26377693 NCBI chr10:82,891,021...82,993,230 JBrowse link
G Arhgap4 Rho GTPase activating protein 4 increases expression ISO benz(a)anthracene results in increased expression of ARHGAP4 mRNA CTD PMID:26377693 NCBI chr  X:151,636,071...151,651,528 JBrowse link
G Arhgap45 Rho GTPase activating protein 45 increases expression ISO benz(a)anthracene results in increased expression of ARHGAP45 mRNA CTD PMID:26377693 NCBI chr 7:9,674,873...9,690,286 JBrowse link
G Arhgef38 Rho guanine nucleotide exchange factor 38 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARHGEF38 mRNA CTD PMID:27858113 NCBI chr 2:221,610,212...221,739,841 JBrowse link
G Arhgef40 Rho guanine nucleotide exchange factor 40 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ARHGEF40 mRNA CTD PMID:27858113 NCBI chr15:24,672,645...24,696,510 JBrowse link
G Arid4a AT-rich interaction domain 4A decreases expression ISO benz(a)anthracene results in decreased expression of ARID4A mRNA CTD PMID:26377693 NCBI chr 6:95,258,429...95,335,987 JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 increases expression ISO benz(a)anthracene results in increased expression of ARIH2 mRNA CTD PMID:26377693 NCBI chr 8:118,175,267...118,234,425 JBrowse link
G Arl5c ARF like GTPase 5C increases expression ISO benz(a)anthracene results in increased expression of ARL5C mRNA CTD PMID:26377693 NCBI chr10:82,985,213...82,993,425 JBrowse link
G Armc6 armadillo repeat containing 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARMC6 mRNA CTD PMID:27858113 NCBI chr16:19,191,106...19,201,528 JBrowse link
G Arrdc2 arrestin domain containing 2 affects expression ISO benz(a)anthracene affects the expression of ARRDC2 mRNA CTD PMID:26377693 NCBI chr16:18,601,897...18,606,029 JBrowse link
G Arrdc4 arrestin domain containing 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARRDC4 mRNA CTD PMID:27858113 NCBI chr 1:122,369,355...122,383,351 JBrowse link
G Art4 ADP-ribosyltransferase 4 increases expression ISO benz(a)anthracene results in increased expression of ART4 mRNA CTD PMID:26377693 NCBI chr 4:171,468,415...171,482,435 JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 decreases expression ISO benz(a)anthracene results in decreased expression of ASCC3 mRNA CTD PMID:26377693 NCBI chr20:53,510,137...53,795,446 JBrowse link
G Asgr1 asialoglycoprotein receptor 1 decreases expression ISO benz(a)anthracene results in decreased expression of ASGR1 mRNA CTD PMID:26377693 NCBI chr10:54,775,727...54,779,642 JBrowse link
G Asgr2 asialoglycoprotein receptor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASGR2 mRNA CTD PMID:27858113 NCBI chr10:54,821,407...54,834,624 JBrowse link
G Asph aspartate-beta-hydroxylase decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ASPH mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASPH mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 5:27,398,933...27,611,519 JBrowse link
G Atad2b ATPase family, AAA domain containing 2B decreases expression ISO benz(a)anthracene results in decreased expression of ATAD2B mRNA CTD PMID:26377693 NCBI chr 6:27,914,546...28,070,103 JBrowse link
G Atg16l2 autophagy related 16-like 2 affects expression ISO benz(a)anthracene affects the expression of ATG16L2 mRNA CTD PMID:26377693 NCBI chr 1:155,687,386...155,703,419 JBrowse link
G Atosa atos homolog A increases expression ISO benz(a)anthracene results in increased expression of ATOSA mRNA CTD PMID:26377693 NCBI chr 8:75,694,828...75,772,565 JBrowse link
G Atp11a ATPase phospholipid transporting 11A increases expression ISO benz(a)anthracene results in increased expression of ATP11A mRNA CTD PMID:26377693 NCBI chr16:76,657,752...76,767,640 JBrowse link
G Atp13a3 ATPase 13A3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP13A3 mRNA CTD PMID:27858113 NCBI chr11:70,364,998...70,442,005 JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ATP2A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr12:34,072,710...34,122,142 JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 decreases expression ISO benz(a)anthracene results in decreased expression of ATP6V0E2 mRNA CTD PMID:26377693 NCBI chr 4:77,484,868...77,488,016 JBrowse link
G Avpr1a arginine vasopressin receptor 1A decreases expression ISO benz(a)anthracene results in decreased expression of AVPR1A mRNA CTD PMID:26377693 NCBI chr 7:59,999,743...60,003,667 JBrowse link
G Azin1 antizyme inhibitor 1 affects expression ISO benz(a)anthracene affects the expression of AZIN1 mRNA CTD PMID:26377693 NCBI chr 7:69,654,773...69,681,578 JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 NCBI chr 5:55,935,614...55,982,461 JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 decreases expression ISO benz(a)anthracene results in decreased expression of B4GALT5 mRNA CTD PMID:26377693 NCBI chr 3:156,018,056...156,033,983 JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase decreases expression ISO benz(a)anthracene results in decreased expression of BAAT mRNA CTD PMID:26377693 NCBI chr 5:68,647,166...68,656,137 JBrowse link
G Bach2 BTB domain and CNC homolog 2 increases expression ISO benz(a)anthracene results in increased expression of BACH2 mRNA CTD PMID:26377693 NCBI chr 5:46,632,338...46,982,676 JBrowse link
G Bag3 BAG cochaperone 3 decreases expression ISO benz(a)anthracene results in decreased expression of BAG3 mRNA CTD PMID:26377693 NCBI chr 1:192,533,460...192,557,281 JBrowse link
G Bank1 B-cell scaffold protein with ankyrin repeats 1 increases expression ISO benz(a)anthracene results in increased expression of BANK1 mRNA CTD PMID:26377693 NCBI chr 2:224,530,475...224,800,420 JBrowse link
G Banp Btg3 associated nuclear protein decreases expression ISO benz(a)anthracene results in decreased expression of BANP mRNA CTD PMID:26377693 NCBI chr19:50,007,710...50,082,742 JBrowse link
G Batf basic leucine zipper ATF-like transcription factor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA CTD PMID:27858113 NCBI chr 6:111,084,717...111,107,052 JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BAX mRNA CTD PMID:27858113 NCBI chr 1:105,076,472...105,081,906 JBrowse link
G Bcl2l14 Bcl2-like 14 increases expression ISO benz(a)anthracene results in increased expression of BCL2L14 mRNA CTD PMID:26377693 NCBI chr 4:167,217,561...167,258,723 JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA CTD PMID:27858113 NCBI chr 1:79,471,368...79,485,908 JBrowse link
G Bcl6b BCL6B, transcription repressor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BCL6B mRNA CTD PMID:27858113 NCBI chr10:54,940,908...54,947,022 JBrowse link
G Bcl7b BAF chromatin remodeling complex subunit BCL7B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 NCBI chr12:27,133,412...27,146,631 JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 increases expression ISO benz(a)anthracene results in increased expression of BCLAF1 mRNA CTD PMID:26377693 NCBI chr 1:16,904,572...16,937,106 JBrowse link
G Bend3 BEN domain containing 3 increases expression ISO benz(a)anthracene results in increased expression of BEND3 mRNA CTD PMID:26377693 NCBI chr20:46,980,246...47,017,059 JBrowse link
G Bfsp2 beaded filament structural protein 2 increases expression ISO benz(a)anthracene results in increased expression of BFSP2 mRNA CTD PMID:26377693 NCBI chr 8:104,006,226...104,063,399 JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 NCBI chr 4:141,618,453...141,624,154 JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA CTD PMID:27858113 NCBI chr10:103,567,369...103,580,069 JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA CTD PMID:27858113 NCBI chr 1:252,973,818...252,980,873 JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of BMAL1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:176,766,222...176,864,741 JBrowse link
G Bmf Bcl2 modifying factor increases expression ISO benz(a)anthracene results in increased expression of BMF mRNA CTD PMID:26377693 NCBI chr 3:125,953,466...125,974,087 JBrowse link
G Bmp7 bone morphogenetic protein 7 decreases expression ISO benz(a)anthracene results in decreased expression of BMP7 mRNA CTD PMID:26377693 NCBI chr 3:182,059,318...182,135,273 JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA CTD PMID:27858113 NCBI chr 9:68,685,942...68,801,353 JBrowse link
G Bmx BMX non-receptor tyrosine kinase increases expression ISO benz(a)anthracene results in increased expression of BMX mRNA CTD PMID:26377693 NCBI chr  X:33,859,128...33,921,876 JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 decreases expression ISO benz(a)anthracene results in decreased expression of BRWD1 mRNA CTD PMID:26377693 NCBI chr11:48,756,174...48,853,692 JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BSCL2 mRNA CTD PMID:27858113 NCBI chr 1:205,731,828...205,743,430 JBrowse link
G Btg1 BTG anti-proliferation factor 1 decreases expression ISO benz(a)anthracene results in decreased expression of BTG1 mRNA CTD PMID:26377693 NCBI chr 7:33,228,149...33,230,406 JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO benz(a)anthracene results in increased expression of BTG2 mRNA CTD PMID:22236718 NCBI chr13:48,083,931...48,087,690 JBrowse link
G Btla B and T lymphocyte associated increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of BTLA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr11:69,069,734...69,099,331 JBrowse link
G C2 complement C2 decreases expression ISO benz(a)anthracene results in decreased expression of C2 mRNA CTD PMID:26377693 NCBI chr20:3,951,474...3,970,376 JBrowse link
G C2cd3 C2 domain containing 3 centriole elongation regulator decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of C2CD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C2CD3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:164,127,304...164,225,088 JBrowse link
G C5 complement C5 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of HC mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HC mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:38,668,174...38,759,468 JBrowse link
G C5ar2 complement C5a receptor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA CTD PMID:27858113 NCBI chr 1:76,930,381...76,945,432 JBrowse link
G C7 complement C7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C7 mRNA CTD PMID:27858113 NCBI chr 2:54,088,116...54,165,102 JBrowse link
G Cabp5 calcium binding protein 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CABP5 mRNA CTD PMID:27858113 NCBI chr 1:74,350,811...74,363,830 JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I increases expression ISO benz(a)anthracene results in increased expression of CACNA1I mRNA CTD PMID:26377693 NCBI chr 7:113,716,266...113,827,670 JBrowse link
G Cacybp calcyclin binding protein decreases expression ISO benz(a)anthracene results in decreased expression of CACYBP mRNA CTD PMID:26377693 NCBI chr13:74,970,917...74,981,298 JBrowse link
G Calcr calcitonin receptor increases expression ISO benz(a)anthracene results in increased expression of CALCR mRNA CTD PMID:26377693 NCBI chr 4:31,661,270...31,736,392 JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma increases expression ISO benz(a)anthracene results in increased expression of CAMK2G mRNA CTD PMID:26377693 NCBI chr15:3,553,238...3,612,310 JBrowse link
G Capn11 calpain 11 increases expression ISO benz(a)anthracene results in increased expression of CAPN11 mRNA CTD PMID:26377693 NCBI chr 9:15,344,059...15,365,604 JBrowse link
G Caps2 calcyphosine 2 increases expression ISO benz(a)anthracene results in increased expression of CAPS2 mRNA CTD PMID:26377693 NCBI chr 7:47,580,636...47,641,598 JBrowse link
G Car14 carbonic anhydrase 14 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of CAR14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAR14 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 2:183,442,263...183,449,231 JBrowse link
G Card11 caspase recruitment domain family, member 11 increases expression ISO benz(a)anthracene results in increased expression of CARD11 mRNA CTD PMID:26377693 NCBI chr12:18,735,088...18,872,045 JBrowse link
G Cav1 caveolin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 NCBI chr 4:46,606,538...46,639,616 JBrowse link
G Cbfa2t3 CBFA2/RUNX1 partner transcriptional co-repressor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CBFA2T3 mRNA CTD PMID:27858113 NCBI chr19:50,679,897...50,750,028 JBrowse link
G Ccbe1 collagen and calcium binding EGF domains 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCBE1 mRNA CTD PMID:27858113 NCBI chr18:61,849,821...62,093,876 JBrowse link
G Ccdc121 coiled-coil domain containing 121 increases expression ISO benz(a)anthracene results in increased expression of CCDC121 mRNA CTD PMID:26377693 NCBI chr 6:24,970,845...24,973,451 JBrowse link
G Ccdc184 coiled-coil domain containing 184 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCDC184 mRNA CTD PMID:27858113 NCBI chr 7:129,297,635...129,301,961 JBrowse link
G Ccdc28b coiled coil domain containing 28B increases expression ISO benz(a)anthracene results in increased expression of CCDC28B mRNA CTD PMID:26377693 NCBI chr 5:141,962,275...141,967,278 JBrowse link
G Ccdc30 coiled-coil domain containing 30 increases expression ISO benz(a)anthracene results in increased expression of CCDC30 mRNA CTD PMID:26377693 NCBI chr 5:132,926,767...133,019,635 JBrowse link
G Ccdc39 coiled-coil domain 39 molecular ruler complex subunit increases expression ISO benz(a)anthracene results in increased expression of CCDC39 mRNA CTD PMID:26377693 NCBI chr 2:116,665,651...116,703,354 JBrowse link
G Ccdc68 coiled-coil domain containing 68 affects expression ISO benz(a)anthracene affects the expression of CCDC68 mRNA CTD PMID:26377693 NCBI chr18:63,541,828...63,584,122 JBrowse link
G Ccdc78 coiled-coil domain containing 78 increases expression ISO benz(a)anthracene results in increased expression of CCDC78 mRNA CTD PMID:26377693 NCBI chr10:14,808,355...14,812,284 JBrowse link
G Ccdc81 coiled-coil domain containing 81 increases expression ISO benz(a)anthracene results in increased expression of CCDC81 mRNA CTD PMID:26377693 NCBI chr 1:143,739,472...143,791,026 JBrowse link
G Ccdc82 coiled-coil domain containing 82 increases expression ISO benz(a)anthracene results in increased expression of CCDC82 mRNA CTD PMID:26377693 NCBI chr 8:18,509,293...18,665,008 JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases expression ISO benz(a)anthracene results in increased expression of CCL11 mRNA CTD PMID:26377693 NCBI chr10:67,525,975...67,530,576 JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [benz(a)anthracene co-treated with TNF protein] results in increased expression of CCL2 mRNA CTD PMID:23396138 NCBI chr10:67,503,077...67,504,875 JBrowse link
G Ccl27 C-C motif chemokine ligand 27 decreases expression ISO benz(a)anthracene results in decreased expression of CCL27A mRNA CTD PMID:26377693 NCBI chr 5:56,941,402...56,948,511 JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL4 mRNA CTD PMID:27858113 NCBI chr10:68,963,893...68,965,728 JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 NCBI chr10:68,820,330...68,824,906 JBrowse link
G Ccl9 C-C motif chemokine ligand 9 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA CTD PMID:27858113 NCBI chr10:68,863,994...68,868,928 JBrowse link
G Ccm2l CCM2 like scaffold protein increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CCM2L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:141,533,470...141,549,136 JBrowse link
G Ccna2 cyclin A2 multiple interactions
increases expression
EXP AHR affects the reaction [benz(a)anthracene results in increased expression of CCNA2 protein]; benz(a)anthracene results in increased activity of [CCNA2 protein binds to CDK2 protein] CTD PMID:17141280 NCBI chr 2:121,355,363...121,361,762 JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND1 mRNA CTD PMID:27858113 NCBI chr 1:209,518,288...209,527,986 JBrowse link
G Ccnd2 cyclin D2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND2 mRNA CTD PMID:27858113 NCBI chr 4:161,653,048...161,675,422 JBrowse link
G Ccng1 cyclin G1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCNG1 mRNA CTD PMID:27858113 NCBI chr10:25,678,503...25,684,876 JBrowse link
G Ccnjl cyclin J-like decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of CCNJL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNJL mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:27,995,682...28,053,428 JBrowse link
G Ccnl1 cyclin L1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of CCNL1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNL1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 2:152,495,169...152,508,855 JBrowse link
G Ccnl2 cyclin L2 affects expression ISO benz(a)anthracene affects the expression of CCNL2 mRNA CTD PMID:26377693 NCBI chr 5:171,698,951...171,711,037 JBrowse link
G Ccr3 C-C motif chemokine receptor 3 increases expression ISO benz(a)anthracene results in increased expression of CCR3 mRNA CTD PMID:26377693 NCBI chr 8:123,586,100...123,634,178 JBrowse link
G Ccr6 C-C motif chemokine receptor 6 increases expression ISO benz(a)anthracene results in increased expression of CCR6 mRNA CTD PMID:26377693 NCBI chr 1:55,022,037...55,055,857 JBrowse link
G Ccr7 C-C motif chemokine receptor 7 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CCR7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCR7 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:84,098,193...84,108,309 JBrowse link
G Cd151 CD151 molecule (Raph blood group) increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CD151 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD151 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:205,994,300...205,998,307 JBrowse link
G Cd19 CD19 molecule increases expression ISO benz(a)anthracene results in increased expression of CD19 mRNA CTD PMID:26377693 NCBI chr 1:190,417,853...190,424,494 JBrowse link
G Cd200 Cd200 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD200 mRNA CTD PMID:27858113 NCBI chr11:68,916,200...68,943,570 JBrowse link
G Cd300c2 CD300C molecule 2 increases expression ISO benz(a)anthracene results in increased expression of CD300C2 mRNA CTD PMID:26377693 NCBI chr10:100,253,312...100,258,553 JBrowse link
G Cd300lf Cd300 molecule-like family member F increases expression ISO benz(a)anthracene results in increased expression of CD300LF mRNA CTD PMID:26377693 NCBI chr10:100,359,942...100,376,130 JBrowse link
G Cd34 CD34 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD34 mRNA CTD PMID:27858113 NCBI chr13:109,008,786...109,029,317 JBrowse link
G Cd37 CD37 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA CTD PMID:27858113 NCBI chr 1:95,719,171...95,724,662 JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD48 mRNA CTD PMID:27858113 NCBI chr13:86,717,960...86,741,540 JBrowse link
G Cd69 Cd69 molecule increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CD69 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD69 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:164,411,485...164,419,403 JBrowse link
G Cd79a CD79a molecule increases expression ISO benz(a)anthracene results in increased expression of CD79A mRNA CTD PMID:26377693 NCBI chr 1:89,621,460...89,625,813 JBrowse link
G Cd79b CD79b molecule increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CD79B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD79B mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:91,739,134...91,742,312 JBrowse link
G Cd84 CD84 molecule increases expression ISO benz(a)anthracene results in increased expression of CD84 mRNA CTD PMID:26377693 NCBI chr13:84,327,580...84,367,153 JBrowse link
G Cd8b CD8 subunit beta increases expression ISO benz(a)anthracene results in increased expression of CD8B1 mRNA CTD PMID:26377693 NCBI chr 4:104,870,911...104,886,838 JBrowse link
G Cd99 CD99 molecule (Xg blood group) multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CD99 mRNA CTD PMID:27858113 NCBI chr20:56,000,494...56,005,140 JBrowse link
G Cdc14b cell division cycle 14B increases expression ISO benz(a)anthracene results in increased expression of CDC14B mRNA CTD PMID:26377693 NCBI chr17:850,272...938,972 JBrowse link
G Cdc40 cell division cycle 40 decreases expression ISO benz(a)anthracene results in decreased expression of CDC40 mRNA CTD PMID:26377693 NCBI chr20:44,273,080...44,325,605 JBrowse link
G Cdh1 cadherin 1 decreases expression ISO benz(a)anthracene results in decreased expression of CDH1 mRNA CTD PMID:26377693 NCBI chr19:51,402,178...51,471,572 JBrowse link
G Cdh16 cadherin 16 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDH16 mRNA CTD PMID:27858113 NCBI chr19:360,824...371,008 JBrowse link
G Cdhr4 cadherin-related family member 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDHR4 mRNA CTD PMID:27858113 NCBI chr 8:108,682,594...108,690,358 JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions EXP benz(a)anthracene results in increased activity of [CCNA2 protein binds to CDK2 protein] CTD PMID:17141280 NCBI chr 7:1,714,392...1,721,964 JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CDKN1A mRNA
benz(a)anthracene results in decreased expression of CDKN1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CDKN1A mRNA
CTD PMID:22236718 PMID:26377693 PMID:27858113 NCBI chr20:7,150,820...7,161,373 JBrowse link
G Celf5 CUGBP, Elav-like family member 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA CTD PMID:27858113 NCBI chr 7:8,225,787...8,250,322 JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 decreases expression ISO benz(a)anthracene results in decreased expression of CELSR2 mRNA CTD PMID:21635667 NCBI chr 2:196,029,206...196,053,848 JBrowse link
G Cep162 centrosomal protein 162 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CEP162 mRNA CTD PMID:27858113 NCBI chr 8:88,149,726...88,208,249 JBrowse link
G Cep70 centrosomal protein 70 increases expression ISO benz(a)anthracene results in increased expression of CEP70 mRNA CTD PMID:26377693 NCBI chr 8:99,810,270...99,863,279 JBrowse link
G Cep85l centrosomal protein 85-like decreases expression ISO benz(a)anthracene results in decreased expression of CEP85L mRNA CTD PMID:26377693 NCBI chr20:32,568,417...32,739,449 JBrowse link
G Cep95 centrosomal protein 95 increases expression ISO benz(a)anthracene results in increased expression of CEP95 mRNA CTD PMID:26377693 NCBI chr10:91,732,111...91,760,095 JBrowse link
G Ces2c carboxylesterase 2C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2C mRNA CTD PMID:27858113 NCBI chr 1:260,391,190...260,398,757 JBrowse link
G Ces2e carboxylesterase 2E multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2E mRNA CTD PMID:27858113 NCBI chr19:157,447...172,822 JBrowse link
G Cfap43 cilia and flagella associated protein 43 increases expression ISO benz(a)anthracene results in increased expression of CFAP43 mRNA CTD PMID:26377693 NCBI chr 1:246,625,259...246,712,438 JBrowse link
G Cfap65 cilia and flagella associated protein 65 increases expression ISO benz(a)anthracene results in increased expression of CFAP65 mRNA CTD PMID:26377693 NCBI chr 9:76,459,211...76,494,199 JBrowse link
G Cfb complement factor B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CFB mRNA CTD PMID:27858113 NCBI chr20:3,970,643...3,976,510 JBrowse link
G Cfl1 cofilin 1 increases expression ISO benz(a)anthracene results in increased expression of CFL1 mRNA CTD PMID:26377693 NCBI chr 1:212,227,124...212,230,656 JBrowse link
G Cgn cingulin increases expression ISO benz(a)anthracene results in increased expression of CGN mRNA CTD PMID:26377693 NCBI chr 2:182,308,389...182,335,747 JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of CHD2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHD2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:136,597,993...136,726,874 JBrowse link
G Chia chitinase, acidic multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA CTD PMID:27858113 NCBI chr 2:196,302,687...196,344,849 JBrowse link
G Chka choline kinase alpha decreases expression ISO benz(a)anthracene results in decreased expression of CHKA mRNA CTD PMID:26377693 NCBI chr 1:210,506,069...210,554,753 JBrowse link
G Chkb choline kinase beta increases expression ISO benz(a)anthracene results in increased expression of CHKB mRNA CTD PMID:26377693 NCBI chr 7:122,380,592...122,385,102 JBrowse link
G Chmp4b charged multivesicular body protein 4B decreases expression ISO benz(a)anthracene results in decreased expression of CHMP4B mRNA CTD PMID:26377693 NCBI chr 3:143,170,859...143,211,376 JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 decreases expression ISO benz(a)anthracene results in decreased expression of CHORDC1 mRNA CTD PMID:26377693 NCBI chr 8:15,374,356...15,398,436 JBrowse link
G Chpf2 chondroitin polymerizing factor 2 affects expression ISO benz(a)anthracene affects the expression of CHPF2 mRNA CTD PMID:26377693 NCBI chr 4:10,578,470...10,585,940 JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit decreases expression ISO benz(a)anthracene results in decreased expression of CHRNA4 mRNA CTD PMID:26377693 NCBI chr 3:168,136,246...168,157,839 JBrowse link
G Chst1 carbohydrate sulfotransferase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHST1 mRNA CTD PMID:27858113 NCBI chr 3:78,552,059...78,574,740 JBrowse link
G Chst3 carbohydrate sulfotransferase 3 increases expression ISO benz(a)anthracene results in increased expression of CHST3 mRNA CTD PMID:26377693 NCBI chr20:28,114,386...28,152,046 JBrowse link
G Chst8 carbohydrate sulfotransferase 8 increases expression ISO benz(a)anthracene results in increased expression of CHST8 mRNA CTD PMID:26377693 NCBI chr 1:87,294,144...87,435,900 JBrowse link
G Ciart circadian associated repressor of transcription increases expression ISO benz(a)anthracene results in increased expression of CIART mRNA CTD PMID:26377693 NCBI chr 2:183,419,819...183,424,845 JBrowse link
G Cib3 calcium and integrin binding family member 3 decreases expression ISO benz(a)anthracene results in decreased expression of CIB3 mRNA CTD PMID:26377693 NCBI chr16:17,622,431...17,631,827 JBrowse link
G Cimap2 ciliary microtubule associated protein 2 increases expression ISO benz(a)anthracene results in increased expression of CIMAP2 mRNA CTD PMID:26377693 NCBI chr 5:121,375,998...121,401,869 JBrowse link
G Cirbp cold inducible RNA binding protein increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CIRBP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CIRBP mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Cish cytokine inducible SH2-containing protein decreases expression ISO benz(a)anthracene results in decreased expression of CISH mRNA CTD PMID:26377693 NCBI chr 8:116,850,969...116,855,917 JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CITED2 mRNA CTD PMID:27858113 NCBI chr 1:12,312,426...12,314,869 JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA CTD PMID:27858113 NCBI chr16:76,542,114...76,567,297 JBrowse link
G Clasrp CLK4-associating serine/arginine rich protein increases expression ISO benz(a)anthracene results in increased expression of SFRS16 mRNA CTD PMID:26377693 NCBI chr 1:79,232,260...79,256,462 JBrowse link
G Cldn1 claudin 1 decreases expression ISO benz(a)anthracene results in decreased expression of CLDN1 mRNA CTD PMID:26377693 NCBI chr11:87,926,376...87,941,533 JBrowse link
G Cldn17 claudin 17 decreases expression ISO benz(a)anthracene results in decreased expression of CLDN17 mRNA CTD PMID:21635667 NCBI chr11:27,827,454...27,828,630 JBrowse link
G Cldn2 claudin 2 decreases expression ISO benz(a)anthracene results in decreased expression of CLDN2 mRNA CTD PMID:26377693 NCBI chr  X:103,459,870...103,473,794 JBrowse link
G Cldnd1 claudin domain containing 1 decreases expression ISO benz(a)anthracene results in decreased expression of CLDND1 mRNA CTD PMID:26377693 NCBI chr11:41,883,120...41,889,471 JBrowse link
G Clec1a C-type lectin domain family 1, member A increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CLEC1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC1A mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:162,875,360...162,902,571 JBrowse link
G Clec4a1 C-type lectin domain family 4, member A1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC4A1 mRNA CTD PMID:27858113 NCBI chr 4:156,173,894...156,186,009 JBrowse link
G Clec4g C-type lectin domain family 4, member G multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CLEC4G mRNA CTD PMID:27858113 NCBI chr12:1,780,370...1,785,027 JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 increases expression ISO benz(a)anthracene results in increased expression of CLIP4 mRNA CTD PMID:26377693 NCBI chr 6:23,616,280...23,697,625
NCBI chr 6:23,718,580...23,729,231
NCBI chr 6:23,597,729...23,601,000
JBrowse link
G Clk1 CDC-like kinase 1 affects expression ISO benz(a)anthracene affects the expression of CLK1 mRNA CTD PMID:26377693 NCBI chr 9:67,441,962...67,453,180 JBrowse link
G Clk2 CDC-like kinase 2 increases expression ISO benz(a)anthracene results in increased expression of CLK2 mRNA CTD PMID:26377693 NCBI chr 2:176,868,423...176,880,412 JBrowse link
G Clk4 CDC-like kinase 4 increases expression ISO benz(a)anthracene results in increased expression of CLK4 mRNA CTD PMID:26377693 NCBI chr10:36,024,364...36,042,366 JBrowse link
G Clmn calmin increases expression ISO benz(a)anthracene results in increased expression of CLMN mRNA CTD PMID:26377693 NCBI chr 6:123,707,710...123,807,283 JBrowse link
G Clmp CXADR-like membrane protein decreases expression ISO benz(a)anthracene results in decreased expression of CLMP mRNA CTD PMID:26377693 NCBI chr 8:41,060,527...41,168,841 JBrowse link
G Clock clock circadian regulator decreases expression ISO benz(a)anthracene results in decreased expression of CLOCK mRNA CTD PMID:26377693 NCBI chr14:32,262,747...32,346,872 JBrowse link
G Clstn2 calsyntenin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLSTN2 mRNA CTD PMID:27858113 NCBI chr 8:98,020,406...98,637,232 JBrowse link
G Cmpk2 cytidine/uridine monophosphate kinase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CMPK2 mRNA CTD PMID:27858113 NCBI chr 6:48,802,150...48,813,652 JBrowse link
G Cntrl centriolin increases expression ISO benz(a)anthracene results in increased expression of CNTRL mRNA CTD PMID:26377693 NCBI chr 3:18,428,147...18,500,362 JBrowse link
G Cobl cordon-bleu WH2 repeat protein decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of COBL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr14:86,828,137...87,060,682 JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A1 mRNA CTD PMID:27858113 NCBI chr10:80,380,458...80,397,461 JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA CTD PMID:27858113 NCBI chr 4:33,518,557...33,553,484 JBrowse link
G Col20a1 collagen type XX alpha 1 chain decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of COL20A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COL20A1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:168,102,475...168,134,759 JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain decreases expression ISO benz(a)anthracene results in decreased expression of COL27A1 mRNA CTD PMID:26377693 NCBI chr 5:76,647,302...76,765,989 JBrowse link
G Col2a1 collagen type II alpha 1 chain decreases expression ISO benz(a)anthracene results in decreased expression of COL2A1 mRNA CTD PMID:21635667 NCBI chr 7:130,977,561...131,006,627 JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA CTD PMID:27858113 NCBI chr 9:54,866,646...54,902,578 JBrowse link
G Col4a4 collagen type IV alpha 4 chain decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of COL4A4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 9:83,833,173...83,875,436 JBrowse link
G Col4a6 collagen type IV alpha 6 chain decreases expression ISO benz(a)anthracene results in decreased expression of COL4A6 mRNA CTD PMID:21635667 NCBI chr  X:109,554,945...109,905,987 JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of COL5A3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL5A3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 8:19,304,564...19,349,809 JBrowse link
G Commd3 COMM domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COMMD3 mRNA CTD PMID:27858113 NCBI chr17:81,327,444...81,331,191 JBrowse link
G Coq10b coenzyme Q10B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ10B mRNA CTD PMID:27858113 NCBI chr 9:56,553,751...56,573,671 JBrowse link
G Coq8a coenzyme Q8A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ8A mRNA CTD PMID:27858113 NCBI chr13:94,436,680...94,465,535 JBrowse link
G Coro2a coronin 2A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CORO2A mRNA CTD PMID:27858113 NCBI chr 5:60,825,630...60,881,917 JBrowse link
G Cplx2 complexin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPLX2 mRNA CTD PMID:27858113 NCBI chr17:10,219,577...10,292,835 JBrowse link
G Cpne4 copine 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPNE4 mRNA CTD PMID:27858113 NCBI chr 8:105,177,376...105,653,075 JBrowse link
G Cpne5 copine 5 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CPNE5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPNE5 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr20:7,206,742...7,289,309 JBrowse link
G Cpt1c carnitine palmitoyltransferase 1c multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA CTD PMID:27858113 NCBI chr 1:95,442,814...95,457,347 JBrowse link
G Cr2 complement C3d receptor 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CR2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr13:109,207,034...109,244,980 JBrowse link
G Crb2 crumbs cell polarity complex component 2 decreases expression ISO benz(a)anthracene results in decreased expression of CRB2 mRNA CTD PMID:26377693 NCBI chr 3:21,542,138...21,564,876 JBrowse link
G Crebzf CREB/ATF bZIP transcription factor affects expression ISO benz(a)anthracene affects the expression of CREBZF mRNA CTD PMID:26377693 NCBI chr 1:153,829,544...153,836,073 JBrowse link
G Crip3 cysteine-rich protein 3 decreases expression ISO benz(a)anthracene results in decreased expression of CRIP3 mRNA CTD PMID:26377693 NCBI chr 9:14,554,450...14,557,344 JBrowse link
G Crk CRK proto-oncogene, adaptor protein decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of CRK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CRK mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:61,028,736...61,054,971 JBrowse link
G Cry2 cryptochrome circadian regulator 2 increases expression ISO benz(a)anthracene results in increased expression of CRY2 mRNA CTD PMID:26377693 NCBI chr 3:98,830,479...98,860,437 JBrowse link
G Csf2ra colony stimulating factor 2 receptor subunit alpha decreases expression ISO benz(a)anthracene results in decreased expression of CSF2RA mRNA CTD PMID:26377693 NCBI chr14:113,219...118,808 JBrowse link
G Csf2rb colony stimulating factor 2 receptor subunit beta increases expression ISO benz(a)anthracene results in increased expression of CSF2RB2 mRNA CTD PMID:26377693 NCBI chr 7:109,876,919...109,901,589 JBrowse link
G Cst8 cystatin 8 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CST8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CST8 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:136,244,586...136,255,412 JBrowse link
G Cstf3 cleavage stimulation factor subunit 3 decreases expression ISO benz(a)anthracene results in decreased expression of CSTF3 mRNA CTD PMID:26377693 NCBI chr 3:90,966,415...91,037,669 JBrowse link
G Cul9 cullin 9 increases expression ISO benz(a)anthracene results in increased expression of CUL9 mRNA CTD PMID:26377693 NCBI chr 9:14,435,948...14,479,552 JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CXCL12 mRNA
bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA]]; Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA]
CTD PMID:22643241 NCBI chr 4:152,060,781...152,073,628 JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 NCBI chr14:13,608,894...13,613,965 JBrowse link
G Cxcr5 C-X-C motif chemokine receptor 5 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CXCR5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR5 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 8:53,738,878...53,756,813 JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCR6 mRNA CTD PMID:27858113 NCBI chr 8:123,434,417...123,439,568 JBrowse link
G Cyld CYLD lysine 63 deubiquitinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYLD mRNA CTD PMID:27858113 NCBI chr19:34,487,491...34,547,311 JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases expression
decreases expression
multiple interactions
EXP
ISO
benz(a)anthracene results in increased expression of CYP17A1 mRNA
benz(a)anthracene results in decreased expression of CYP17A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA
CTD PMID:23358148 PMID:26377693 PMID:27858113 NCBI chr 1:245,535,462...245,543,148 JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases metabolic processing
increases expression
increases activity
ISO
EXP
[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 protein; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; AHR protein promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; benz(a)anthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; Cadmium Chloride inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; CYP1A1 gene polymorphism affects the reaction [benz(a)anthracene results in increased expression of CYP1A1 protein]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benz(a)anthracene]; lead nitrate inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA; Dactinomycin promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benz(a)anthracene]; resveratrol inhibits the reaction [[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA]
benz(a)anthracene results in increased expression of CYP1A1 mRNA; benz(a)anthracene results in increased expression of CYP1A1 protein
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; [chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with benz(a)anthracene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 protein]; AHR affects the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]]; NR3C1 protein promotes the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]]; Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]
CTD PMID:1358564 PMID:1521541 PMID:1846074 PMID:1934297 PMID:2052000 More... NCBI chr 8:66,991,940...66,998,014 JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression
decreases activity
affects response to substance
ISO
EXP
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene]
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene]
benz(a)anthracene results in increased expression of CYP1A2 mRNA
benz(a)anthracene results in decreased activity of CYP1A2 protein
CYP1A2 protein affects the susceptibility to benz(a)anthracene
[chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA
CTD PMID:7750161 PMID:8961944 PMID:9783729 PMID:11162773 PMID:17253728 More... NCBI chr 8:66,971,261...66,978,149 JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases stability
increases expression
ISO
EXP
[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 protein; [benz(a)anthracene co-treated with TNF protein] results in increased expression of CYP1B1 mRNA; AHR protein affects the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1B1 mRNA; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA; benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Dehydroepiandrosterone inhibits the reaction [benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; Dehydroepiandrosterone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]
benz(a)anthracene results in increased stability of CYP1B1 protein
[benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; [chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with benz(a)anthracene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1B1 mRNA; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]; Hydrocortisone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]; Hydrocortisone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]; Progesterone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]
benz(a)anthracene results in increased expression of CYP1B1 mRNA; benz(a)anthracene results in increased expression of CYP1B1 protein
CTD PMID:7505439 PMID:8022408 PMID:8674863 PMID:9783729 PMID:10037446 More... NCBI chr 6:21,093,927...21,103,091 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression ISO benz(a)anthracene results in increased expression of CYP2E1 mRNA CTD PMID:26377693 NCBI chr 1:205,269,967...205,280,365 JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases expression ISO benz(a)anthracene results in decreased expression of CYP2J9 mRNA CTD PMID:26377693 NCBI chr 5:116,295,691...116,323,219 JBrowse link
G Cys1 cystin 1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of CYS1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYS1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 6:41,300,836...41,318,071 JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 increases expression ISO benz(a)anthracene results in increased expression of DACT2 mRNA CTD PMID:26377693 NCBI chr 1:63,854,182...63,864,153 JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA decreases expression ISO benz(a)anthracene results in decreased expression of DANCR mRNA CTD PMID:26377693 NCBI chr14:34,481,052...34,482,032 JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DARS1 mRNA CTD PMID:27858113 NCBI chr13:39,857,936...39,913,055 JBrowse link
G Dbp D-box binding PAR bZIP transcription factor increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of DBP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DBP mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:96,175,796...96,180,745 JBrowse link
G Dcaf12l2 DDB1 and CUL4 associated factor 12-like 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of DCAF12L2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr  X:123,293,761...123,296,550 JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA CTD PMID:27858113 NCBI chr 6:103,154,847...103,180,992 JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCC mRNA CTD PMID:27858113 NCBI chr18:64,868,987...65,972,783 JBrowse link
G Dcdc2 doublecortin domain containing 2 decreases expression ISO benz(a)anthracene results in decreased expression of DCDC2A mRNA CTD PMID:26377693 NCBI chr17:40,274,009...40,459,757 JBrowse link
G Dcn decorin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCN mRNA CTD PMID:27858113 NCBI chr 7:34,167,973...34,208,004 JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 NCBI chr 2:234,667,499...234,800,322 JBrowse link
G Ddb2 damage specific DNA binding protein 2 increases expression ISO benz(a)anthracene results in increased expression of DDB2 mRNA CTD PMID:26377693 NCBI chr 3:77,185,114...77,207,650 JBrowse link
G Ddc dopa decarboxylase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDC mRNA CTD PMID:27858113 NCBI chr14:86,378,685...86,469,189 JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIAS mRNA CTD PMID:27858113 NCBI chr 1:146,906,150...146,930,462 JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIT4L mRNA CTD PMID:27858113 NCBI chr 2:226,128,273...226,131,044 JBrowse link
G Ddx17 DEAD-box helicase 17 decreases expression ISO benz(a)anthracene results in decreased expression of DDX17 mRNA CTD PMID:26377693 NCBI chr 7:111,091,127...111,109,353 JBrowse link
G Ddx25 DEAD-box helicase 25 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX25 mRNA CTD PMID:27858113 NCBI chr 8:33,894,224...33,910,377 JBrowse link
G Ddx5 DEAD-box helicase 5 affects expression
multiple interactions
ISO benz(a)anthracene affects the expression of DDX5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX5 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:91,723,508...91,732,210 JBrowse link
G Dennd1c DENN domain containing 1C increases expression ISO benz(a)anthracene results in increased expression of DENND1C mRNA CTD PMID:26377693 NCBI chr 9:1,991,035...2,003,330 JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA CTD PMID:27858113 NCBI chr 1:153,454,078...153,484,432 JBrowse link
G Dgkq diacylglycerol kinase, theta increases expression ISO benz(a)anthracene results in increased expression of DGKQ mRNA CTD PMID:26377693 NCBI chr14:1,203,380...1,217,536 JBrowse link
G Dhrs7b dehydrogenase/reductase 7B decreases expression ISO benz(a)anthracene results in decreased expression of DHRS7B mRNA CTD PMID:26377693 NCBI chr10:45,504,344...45,537,094 JBrowse link
G Dhx34 DExH-box helicase 34 increases expression ISO benz(a)anthracene results in increased expression of DHX34 mRNA CTD PMID:26377693 NCBI chr 1:76,880,867...76,905,148 JBrowse link
G Dhx35 DEAH-box helicase 35 increases expression ISO benz(a)anthracene results in increased expression of DHX35 mRNA CTD PMID:26377693 NCBI chr 3:147,450,178...147,507,473 JBrowse link
G Dhx58 DEXH-box helicase 58 decreases expression ISO benz(a)anthracene results in decreased expression of DHX58 mRNA CTD PMID:26377693 NCBI chr10:85,620,352...85,631,776 JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of DIAP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIAP1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr18:29,669,659...29,769,070 JBrowse link
G Dido1 death inducer-obliterator 1 multiple interactions
affects expression
ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIDO1 mRNA
benz(a)anthracene affects the expression of DIDO1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:188,150,100...188,203,445 JBrowse link
G Dio2 iodothyronine deiodinase 2 decreases expression ISO benz(a)anthracene results in decreased expression of DIO2 mRNA CTD PMID:26377693 NCBI chr 6:115,396,308...115,410,594 JBrowse link
G Dipk1b divergent protein kinase domain 1B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DIPK1B mRNA CTD PMID:27858113 NCBI chr 3:29,852,710...29,862,248 JBrowse link
G Diras2 DIRAS family GTPase 2 decreases expression ISO benz(a)anthracene results in decreased expression of DIRAS2 mRNA CTD PMID:26377693 NCBI chr17:12,730,040...12,761,511 JBrowse link
G Dmp1 dentin matrix acidic phosphoprotein 1 increases expression ISO benz(a)anthracene results in increased expression of DMP1 mRNA CTD PMID:19000923 NCBI chr14:5,833,111...5,867,154 JBrowse link
G Dnaaf4 dynein axonemal assembly factor 4 increases expression ISO benz(a)anthracene results in increased expression of DNAAF4 mRNA CTD PMID:26377693 NCBI chr 8:82,577,044...82,601,653 JBrowse link
G Dnah10 dynein, axonemal, heavy chain 10 increases expression ISO benz(a)anthracene results in increased expression of DNAH10 mRNA CTD PMID:26377693 NCBI chr12:37,484,444...37,607,810 JBrowse link
G Dnah2 dynein, axonemal, heavy chain 2 increases expression ISO benz(a)anthracene results in increased expression of DNAH2 mRNA CTD PMID:26377693 NCBI chr10:54,142,648...54,268,901 JBrowse link
G Dnah8 dynein, axonemal, heavy chain 8 increases expression ISO benz(a)anthracene results in increased expression of DNAH8 mRNA CTD PMID:26377693 NCBI chr20:8,692,939...8,946,780 JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of DNAJA1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJA1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 5:55,842,414...55,853,326 JBrowse link
G Dnaja4 DnaJ heat shock protein family (Hsp40) member A4 decreases expression ISO benz(a)anthracene results in decreased expression of DNAJA4 mRNA CTD PMID:26377693 NCBI chr 8:55,085,246...55,102,715 JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression ISO benz(a)anthracene results in decreased expression of DNAJB1 mRNA CTD PMID:26377693 NCBI chr19:41,427,453...41,431,141 JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA CTD PMID:27858113 NCBI chr 2:243,790,296...243,819,042 JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 decreases expression ISO benz(a)anthracene results in decreased expression of DNAJC21 mRNA CTD PMID:26377693 NCBI chr 2:59,419,507...59,446,746 JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA CTD PMID:27858113 NCBI chr 5:150,029,064...150,047,115 JBrowse link
G Dock6 dedicator of cytokinesis 6 increases expression ISO benz(a)anthracene results in increased expression of DOCK6 mRNA CTD PMID:26377693 NCBI chr 8:20,342,430...20,394,660 JBrowse link
G Dok3 docking protein 3 increases expression ISO benz(a)anthracene results in increased expression of DOK3 mRNA CTD PMID:26377693 NCBI chr17:9,109,633...9,115,188 JBrowse link
G Dot1l DOT1 like histone lysine methyltransferase increases expression ISO benz(a)anthracene results in increased expression of DOT1L mRNA CTD PMID:26377693 NCBI chr 7:8,918,764...8,959,474 JBrowse link
G Drd1 dopamine receptor D1 multiple interactions ISO [Particulate Matter results in increased abundance of benz(a)anthracene] which results in decreased expression of DRD1 mRNA CTD PMID:38739786 NCBI chr17:10,545,488...10,550,029 JBrowse link
G Dst dystonin decreases expression ISO benz(a)anthracene results in decreased expression of DST mRNA CTD PMID:26377693 NCBI chr 9:36,135,657...36,529,617 JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DTL mRNA CTD PMID:27858113 NCBI chr13:105,646,908...105,685,921 JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DTX4 mRNA CTD PMID:27858113 NCBI chr 1:209,457,719...209,545,163 JBrowse link
G Dusp2 dual specificity phosphatase 2 increases expression ISO benz(a)anthracene results in increased expression of DUSP2 mRNA CTD PMID:26377693 NCBI chr 3:135,009,636...135,011,821 JBrowse link
G Dvl3 dishevelled segment polarity protein 3 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of DVL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DVL3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr11:80,365,446...80,382,641 JBrowse link
G Dync2i1 dynein 2 intermediate chain 1 increases expression ISO benz(a)anthracene results in increased expression of DYNC2I1 mRNA CTD PMID:26377693 NCBI chr 6:137,133,418...137,189,937 JBrowse link
G Dzip1 DAZ interacting zinc finger protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DZIP1 mRNA CTD PMID:27858113 NCBI chr15:95,956,329...96,009,994 JBrowse link
G Echdc2 enoyl CoA hydratase domain containing 2 decreases expression ISO benz(a)anthracene results in decreased expression of ECHDC2 mRNA CTD PMID:26377693 NCBI chr 5:122,915,874...122,934,860 JBrowse link
G Ecm1 extracellular matrix protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ECM1 mRNA CTD PMID:27858113 NCBI chr 2:183,287,491...183,292,729 JBrowse link
G Edn1 endothelin 1 increases expression ISO benz(a)anthracene results in increased expression of EDN1 mRNA CTD PMID:26377693 NCBI chr17:22,660,799...22,666,687 JBrowse link
G Ednrb endothelin receptor type B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 NCBI chr15:87,055,490...87,086,765 JBrowse link
G Eeig1 estrogen-induced osteoclastogenesis regulator 1 increases expression ISO benz(a)anthracene results in increased expression of EEIG1 mRNA CTD PMID:26377693 NCBI chr 3:15,822,441...15,854,651 JBrowse link
G Efcab12 EF-hand calcium binding domain 12 increases expression ISO benz(a)anthracene results in increased expression of EFCAB12 mRNA CTD PMID:26377693 NCBI chr 4:148,869,381...148,892,922 JBrowse link
G Efhb EF hand domain family, member B increases expression ISO benz(a)anthracene results in increased expression of EFHB mRNA CTD PMID:26377693 NCBI chr 9:6,608,791...6,680,104 JBrowse link
G Efnb1 ephrin B1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA CTD PMID:27858113 NCBI chr  X:64,257,351...64,270,158 JBrowse link
G Egf epidermal growth factor multiple interactions ISO AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]]; benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein] CTD PMID:6309801 NCBI chr 2:220,893,660...220,976,331 JBrowse link
G Egfl7 EGF-like-domain, multiple 7 increases expression ISO benz(a)anthracene results in increased expression of EGFL7 mRNA CTD PMID:26377693 NCBI chr 3:29,802,481...29,814,966 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]]; benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein] CTD PMID:6309801 NCBI chr14:95,378,626...95,551,358 JBrowse link
G Ehbp1 EH domain binding protein 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of EHBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EHBP1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr14:96,093,327...96,380,502 JBrowse link
G Ehd1 EH-domain containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD1 mRNA CTD PMID:27858113 NCBI chr 1:203,579,850...203,602,226 JBrowse link
G Ehd4 EH-domain containing 4 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of EHD4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD4 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:107,058,191...107,121,985 JBrowse link
G Eif2ak4 eukaryotic translation initiation factor 2 alpha kinase 4 increases expression ISO benz(a)anthracene results in increased expression of EIF2AK4 mRNA CTD PMID:26377693 NCBI chr 3:125,810,207...125,895,574 JBrowse link
G Eif2s3y eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked increases expression ISO benz(a)anthracene results in increased expression of EIF2S3Y mRNA CTD PMID:26377693 NCBI chr  Y:869,654...889,341 JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J decreases expression ISO benz(a)anthracene results in decreased expression of EIF3J mRNA CTD PMID:26377693 NCBI chr 3:108,985,103...109,007,341 JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO benz(a)anthracene results in increased expression of ELOVL1 mRNA CTD PMID:26377693 NCBI chr 5:131,961,478...131,965,961 JBrowse link
G Emcn endomucin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA CTD PMID:27858113 NCBI chr 2:228,564,445...228,644,370 JBrowse link
G Eml1 EMAP like 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EML1 mRNA CTD PMID:27858113 NCBI chr 6:127,283,968...127,457,246 JBrowse link
G Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 decreases expression ISO benz(a)anthracene results in decreased expression of ENPP3 mRNA CTD PMID:26377693 NCBI chr 1:20,563,700...20,635,044 JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of EPB41 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EPB41 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 5:144,110,010...144,264,037 JBrowse link
G Epha1 Eph receptor A1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of EPHA1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:72,213,022...72,227,543 JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression
ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHX1 mRNA; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benz(a)anthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene]
benz(a)anthracene results in increased expression of EPHX1 protein
CTD PMID:2208584 PMID:8961944 PMID:27858113 NCBI chr13:95,246,079...95,275,852 JBrowse link
G Epm2aip1 EPM2A interacting protein 1 increases expression ISO benz(a)anthracene results in increased expression of EPM2AIP1 mRNA CTD PMID:26377693 NCBI chr 8:120,112,265...120,119,613 JBrowse link
G Epor erythropoietin receptor increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of EPOR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPOR mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 8:28,765,738...28,770,371 JBrowse link
G Eps8l1 EPS8 signaling adaptor L1 increases expression ISO benz(a)anthracene results in increased expression of EPS8L1 mRNA CTD PMID:26377693 NCBI chr 1:69,343,202...69,359,778 JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 decreases expression ISO benz(a)anthracene results in decreased expression of ERBB2 mRNA CTD PMID:21635667 NCBI chr10:83,907,491...83,931,365 JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit increases expression ISO benz(a)anthracene results in increased expression of ERCC1 mRNA CTD PMID:22236718 NCBI chr 1:78,971,310...79,007,963 JBrowse link
G Ermn ermin multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA CTD PMID:27858113 NCBI chr 3:42,628,160...42,633,816 JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression
increases phosphorylation
decreases expression
increases activity
ISO
EXP
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with chrysene] results in increased expression of ESR1 mRNA; benz(a)anthracene promotes the reaction [Estradiol results in increased activity of ESR1 protein]; fulvestrant inhibits the reaction [benz(a)anthracene promotes the reaction [Estradiol results in increased activity of ESR1 protein]]
benz(a)anthracene results in increased expression of ESR1 mRNA
benz(a)anthracene results in increased phosphorylation of ESR1 protein
benz(a)anthracene results in decreased expression of ESR1 protein
benz(a)anthracene results in increased activity of ESR1 protein
CTD PMID:11922773 PMID:12441364 PMID:18634860 PMID:21783948 PMID:25012808 NCBI chr 1:43,511,685...43,904,454 JBrowse link
G Etfbkmt electron transfer flavoprotein subunit beta lysine methyltransferase increases expression ISO benz(a)anthracene results in increased expression of ETFBKMT mRNA CTD PMID:26377693 NCBI chr 4:182,140,492...182,204,635 JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ETS1 mRNA]; SB 203580 inhibits the reaction [benz(a)anthracene results in increased expression of ETS1 mRNA] CTD PMID:21635667 NCBI chr 8:39,303,936...39,426,022 JBrowse link
G Etv5 ETS variant transcription factor 5 increases expression ISO benz(a)anthracene results in increased expression of ETV5 mRNA CTD PMID:26377693 NCBI chr11:78,608,618...78,666,221 JBrowse link
G Eva1a eva-1 homolog A, regulator of programmed cell death increases expression ISO benz(a)anthracene results in increased expression of EVA1A mRNA CTD PMID:26377693 NCBI chr 4:114,593,773...114,643,011 JBrowse link
G Ewsr1 EWS RNA-binding protein 1 increases expression ISO benz(a)anthracene results in increased expression of EWSR1 mRNA CTD PMID:26377693 NCBI chr14:79,965,365...79,994,108 JBrowse link
G Exoc3l1 exocyst complex component 3-like 1 increases expression ISO benz(a)anthracene results in increased expression of EXOC3L mRNA CTD PMID:26377693 NCBI chr19:33,166,836...33,174,371 JBrowse link
G Exoc4 exocyst complex component 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EXOC4 mRNA CTD PMID:27858113 NCBI chr 4:62,774,896...63,551,541 JBrowse link
G Exoc6b exocyst complex component 6B decreases expression ISO benz(a)anthracene results in decreased expression of EXOC6B mRNA CTD PMID:26377693 NCBI chr 4:117,094,741...117,550,221 JBrowse link
G Exosc7 exosome component 7 increases expression ISO benz(a)anthracene results in increased expression of EXOSC7 mRNA CTD PMID:26377693 NCBI chr 8:122,773,607...122,798,943 JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression ISO benz(a)anthracene results in increased expression of FABP1 mRNA CTD PMID:26377693 NCBI chr 4:104,744,302...104,753,119 JBrowse link
G Fabp12 fatty acid binding protein 12 increases expression ISO benz(a)anthracene results in increased expression of FABP12 mRNA CTD PMID:26377693 NCBI chr 2:91,539,568...91,554,999 JBrowse link
G Fam107a family with sequence similarity 107, member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 NCBI chr15:19,038,726...19,060,644 JBrowse link
G Fam110d family with sequence similarity 110, member D multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM110D mRNA CTD PMID:27858113 NCBI chr 5:146,471,048...146,474,019 JBrowse link
G Fam133b family with sequence similarity 133, member B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM133B mRNA CTD PMID:27858113 NCBI chr 4:30,589,646...30,616,291 JBrowse link
G Fam135a family with sequence similarity 135, member A increases expression ISO benz(a)anthracene results in increased expression of FAM135A mRNA CTD PMID:26377693 NCBI chr 9:26,420,116...26,500,803 JBrowse link
G Fam13c family with sequence similarity 13, member C multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM13C mRNA CTD PMID:27858113 NCBI chr20:18,064,706...18,186,888 JBrowse link
G Fam193b family with sequence similarity 193, member B affects expression ISO benz(a)anthracene affects the expression of FAM193B mRNA CTD PMID:26377693 NCBI chr17:9,066,818...9,099,511 JBrowse link
G Fam20b FAM20B, glycosaminoglycan xylosylkinase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM20B mRNA CTD PMID:27858113 NCBI chr13:68,801,663...68,839,979 JBrowse link
G Fam76b family with sequence similarity 76, member B increases expression ISO benz(a)anthracene results in increased expression of FAM76B mRNA CTD PMID:26377693 NCBI chr 8:18,971,357...18,993,442 JBrowse link
G Farp1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of FARP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr15:98,124,304...98,363,299 JBrowse link
G Fastk Fas-activated serine/threonine kinase increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of FASTK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:11,624,697...11,628,769 JBrowse link
G Fbxl12 F-box and leucine-rich repeat protein 12 increases expression ISO benz(a)anthracene results in increased expression of FBXL12 mRNA CTD PMID:26377693 NCBI chr 8:19,175,864...19,183,373 JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 increases expression ISO benz(a)anthracene results in increased expression of FBXL13 mRNA CTD PMID:26377693 NCBI chr 4:13,414,880...13,607,079 JBrowse link
G Fbxl20 F-box and leucine-rich repeat protein 20 increases expression ISO benz(a)anthracene results in increased expression of FBXL20 mRNA CTD PMID:26377693 NCBI chr10:83,577,038...83,640,022 JBrowse link
G Fcer2 Fc epsilon receptor II increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of FCER2A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FCER2A mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr12:1,742,809...1,754,476 JBrowse link
G Fcmr Fc mu receptor increases expression ISO benz(a)anthracene results in increased expression of FCMR mRNA CTD PMID:26377693 NCBI chr13:42,337,363...42,351,706 JBrowse link
G Fcrla Fc receptor-like A increases expression ISO benz(a)anthracene results in increased expression of FCRLA mRNA CTD PMID:26377693 NCBI chr13:83,160,453...83,170,170 JBrowse link
G Fgd6 FYVE, RhoGEF and PH domain containing 6 decreases expression ISO benz(a)anthracene results in decreased expression of FGD6 mRNA CTD PMID:26377693 NCBI chr 7:28,597,609...28,712,908 JBrowse link
G Fgf7 fibroblast growth factor 7 increases expression ISO benz(a)anthracene results in increased expression of FGF7 mRNA CTD PMID:26377693 NCBI chr 3:133,734,557...133,786,678 JBrowse link
G Fgf9 fibroblast growth factor 9 increases expression ISO benz(a)anthracene results in increased expression of FGF9 mRNA CTD PMID:19358281 NCBI chr15:32,208,993...32,254,952 JBrowse link
G Fgfr1op2 FGFR1 oncogene partner 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of FGFR1OP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:179,491,602...179,512,630 JBrowse link
G Fgg fibrinogen gamma chain increases expression ISO benz(a)anthracene results in increased expression of FGG mRNA CTD PMID:26377693 NCBI chr 2:168,354,880...168,362,325 JBrowse link
G Fibin fin bud initiation factor homolog multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FIBIN mRNA CTD PMID:27858113 NCBI chr 3:96,942,405...96,944,676 JBrowse link
G Fig4 FIG4 phosphoinositide 5-phosphatase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIG4 mRNA CTD PMID:27858113 NCBI chr20:44,600,603...44,724,047 JBrowse link
G Fignl1 fidgetin-like 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIGNL1 mRNA CTD PMID:27858113 NCBI chr14:86,368,670...86,381,728 JBrowse link
G Fkbp1a FKBP prolyl isomerase 1A decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of FKBP1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FKBP1A mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:160,500,748...160,520,492 JBrowse link
G Flii FLII, actin remodeling protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FLII mRNA CTD PMID:27858113 NCBI chr10:45,893,566...45,907,547 JBrowse link
G Flt3lg Fms related receptor tyrosine kinase 3 ligand increases expression ISO benz(a)anthracene results in increased expression of FLT3L mRNA CTD PMID:26377693 NCBI chr 1:104,751,518...104,756,925 JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA CTD PMID:27858113 NCBI chr13:75,182,184...75,214,439 JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMR1 mRNA CTD PMID:27858113 NCBI chr  X:147,240,239...147,278,057 JBrowse link
G Fn3k fructosamine 3 kinase decreases expression ISO benz(a)anthracene results in decreased expression of FN3K mRNA CTD PMID:26377693 NCBI chr10:107,198,566...107,214,176 JBrowse link
G Fnbp4 formin binding protein 4 increases expression ISO benz(a)anthracene results in increased expression of FNBP4 mRNA CTD PMID:26377693 NCBI chr 3:97,188,852...97,218,916 JBrowse link
G Fndc1 fibronectin type III domain containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FNDC1 mRNA CTD PMID:27858113 NCBI chr 1:47,281,839...47,364,247 JBrowse link
G Folr2 folate receptor beta decreases expression ISO benz(a)anthracene results in decreased expression of FOLR2 mRNA CTD PMID:26377693 NCBI chr 1:165,612,047...165,630,382 JBrowse link
G Foxa2 forkhead box A2 decreases expression ISO benz(a)anthracene results in decreased expression of FOXA2 mRNA CTD PMID:26377693 NCBI chr 3:135,470,123...135,474,326 JBrowse link
G Foxf1 forkhead box F1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FOXF1 mRNA CTD PMID:27858113 NCBI chr19:49,153,949...49,157,741 JBrowse link
G Foxq1 forkhead box Q1 decreases expression ISO benz(a)anthracene results in decreased expression of FOXQ1 mRNA CTD PMID:26377693 NCBI chr17:32,912,744...32,915,377 JBrowse link
G Foxs1 forkhead box S1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FOXS1 mRNA CTD PMID:27858113 NCBI chr 3:141,397,012...141,398,296 JBrowse link
G Fras1 Fraser extracellular matrix complex subunit 1 decreases expression ISO benz(a)anthracene results in decreased expression of FRAS1 mRNA CTD PMID:26377693 NCBI chr14:12,791,407...13,200,862 JBrowse link
G Frem1 Fras1 related extracellular matrix 1 decreases expression ISO benz(a)anthracene results in decreased expression of FREM1 mRNA CTD PMID:21635667 NCBI chr 5:97,321,266...97,469,523 JBrowse link
G Frg1 FSHD region gene 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of FRG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRG1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr16:50,925,783...50,946,661 JBrowse link
G Frmd4b FERM domain containing 4B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRMD4B mRNA CTD PMID:27858113 NCBI chr 4:131,452,361...131,778,734 JBrowse link
G Fscn3 fascin actin-bundling protein 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA CTD PMID:27858113 NCBI chr 4:57,042,797...57,052,224 JBrowse link
G Fus Fus RNA binding protein increases expression ISO benz(a)anthracene results in increased expression of FUS mRNA CTD PMID:26377693 NCBI chr 1:182,576,479...182,590,417 JBrowse link
G Fzd4 frizzled class receptor 4 increases expression ISO benz(a)anthracene results in increased expression of FZD4 mRNA CTD PMID:26377693 NCBI chr 1:143,279,934...143,288,799 JBrowse link
G Fzd6 frizzled class receptor 6 increases expression ISO benz(a)anthracene results in increased expression of FZD6 mRNA CTD PMID:26377693 NCBI chr 7:70,055,012...70,086,781 JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 increases expression ISO benz(a)anthracene results in increased expression of GABBR1 mRNA CTD PMID:26377693 NCBI chr20:1,469,779...1,499,352 JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO benz(a)anthracene metabolite results in increased expression of GADD45A protein; benz(a)anthracene results in increased expression of GADD45A mRNA CTD PMID:22236718 PMID:31051210 NCBI chr 4:97,484,497...97,486,799 JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma decreases expression ISO benz(a)anthracene results in decreased expression of GADD45G mRNA CTD PMID:26377693 NCBI chr17:13,528,606...13,530,351 JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 decreases expression ISO benz(a)anthracene results in decreased expression of GALNT15 mRNA CTD PMID:26377693 NCBI chr16:7,227,232...7,267,002 JBrowse link
G Gas1 growth arrest-specific 1 decreases expression ISO benz(a)anthracene results in decreased expression of GAS1 mRNA CTD PMID:26377693 NCBI chr17:4,487,716...4,490,701 JBrowse link
G Gas5 growth arrest specific 5 increases expression ISO benz(a)anthracene results in increased expression of GAS5 mRNA CTD PMID:26377693 NCBI chr13:73,303,611...73,306,932 JBrowse link
G Gas6 growth arrest specific 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GAS6 mRNA CTD PMID:27858113 NCBI chr16:82,747,676...82,778,090 JBrowse link
G Gask1b golgi associated kinase 1B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GASK1B mRNA CTD PMID:27858113 NCBI chr 2:165,047,689...165,112,479 JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GATA2 mRNA CTD PMID:27858113 NCBI chr 4:120,654,205...120,667,763 JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO benz(a)anthracene results in decreased expression of GBE1 mRNA CTD PMID:26377693 NCBI chr11:8,734,806...9,000,226 JBrowse link
G Gbp6 guanylate binding protein family member 6 decreases expression ISO benz(a)anthracene results in decreased expression of GBP6 mRNA CTD PMID:26377693 NCBI chr14:5,034,999...5,062,023 JBrowse link
G Gcc2 GRIP and coiled-coil domain containing 2 increases expression ISO benz(a)anthracene results in increased expression of GCC2 mRNA CTD PMID:26377693 NCBI chr20:26,247,394...26,293,613 JBrowse link
G Gcgr glucagon receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GCGR mRNA CTD PMID:27858113 NCBI chr10:106,306,803...106,314,970 JBrowse link
G Gcm1 glial cells missing transcription factor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GCM1 mRNA CTD PMID:27858113 NCBI chr 8:78,925,687...78,938,924 JBrowse link
G Gdf10 growth differentiation factor 10 increases expression ISO benz(a)anthracene results in increased expression of GDF10 mRNA CTD PMID:26377693 NCBI chr16:9,237,182...9,250,537 JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA CTD PMID:27858113 NCBI chr16:18,838,436...18,842,022 JBrowse link
G Gdnf glial cell derived neurotrophic factor increases expression ISO benz(a)anthracene results in increased expression of GDNF mRNA CTD PMID:26377693 NCBI chr 2:58,621,327...58,647,242 JBrowse link
G Gfra4 GDNF family receptor alpha 4 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of GFRA4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GFRA4 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:118,254,937...118,262,252 JBrowse link
G Gja5 gap junction protein, alpha 5 decreases expression ISO benz(a)anthracene results in decreased expression of GJA5 mRNA CTD PMID:26377693 NCBI chr 2:187,291,227...187,310,770 JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GJB1 mRNA CTD PMID:27858113 NCBI chr  X:66,501,848...66,509,783 JBrowse link
G Gjc2 gap junction protein, gamma 2 decreases expression ISO benz(a)anthracene results in decreased expression of GJC2 mRNA CTD PMID:26377693 NCBI chr10:43,962,642...43,971,358 JBrowse link
G Gkn2 gastrokine 2 increases expression ISO benz(a)anthracene results in increased expression of GKN2 mRNA CTD PMID:26377693 NCBI chr 4:119,778,326...119,824,366 JBrowse link
G Glis2 GLIS family zinc finger 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GLIS2 mRNA CTD PMID:27858113 NCBI chr10:11,457,594...11,484,948 JBrowse link
G Glt8d1 glycosyltransferase 8 domain containing 1 decreases expression ISO benz(a)anthracene results in decreased expression of GLT8D1 mRNA CTD PMID:26377693 NCBI chr16:6,192,269...6,207,227 JBrowse link
G Glt8d2 glycosyltransferase 8 domain containing 2 decreases expression ISO benz(a)anthracene results in decreased expression of GLT8D2 mRNA CTD PMID:26377693 NCBI chr 7:21,029,534...21,081,081 JBrowse link
G Gmnn geminin, DNA replication inhibitor increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of GMNN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GMNN mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr17:40,729,760...40,738,077 JBrowse link
G Gon4l gon-4 like decreases expression ISO benz(a)anthracene results in decreased expression of GON4L mRNA CTD PMID:26377693 NCBI chr 2:176,531,274...176,604,446 JBrowse link
G Gpcpd1 glycerophosphocholine phosphodiesterase 1 increases expression ISO benz(a)anthracene results in increased expression of GPCPD1 mRNA CTD PMID:26377693 NCBI chr 3:119,787,681...119,832,550 JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions
increases activity
ISO benz(a)anthracene inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein]
benz(a)anthracene results in increased activity of GPD1 protein
CTD PMID:10497882 NCBI chr 7:130,842,526...130,851,530 JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPIHBP1 mRNA CTD PMID:27858113 NCBI chr 7:107,285,584...107,288,702 JBrowse link
G Gpr174 G protein-coupled receptor 174 increases expression ISO benz(a)anthracene results in increased expression of GPR174 mRNA CTD PMID:26377693 NCBI chr  X:72,355,452...72,396,146 JBrowse link
G Gpr4 G protein-coupled receptor 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GPR4 mRNA CTD PMID:27858113 NCBI chr 1:78,865,376...78,877,126 JBrowse link
G Gprin3 GPRIN family member 3 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of GPRIN3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPRIN3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:88,572,062...88,657,369 JBrowse link
G Gpx6 glutathione peroxidase 6 increases expression ISO benz(a)anthracene results in increased expression of GPX6 mRNA CTD PMID:26377693 NCBI chr17:43,408,472...43,416,091 JBrowse link
G Gramd1a GRAM domain containing 1A increases expression ISO benz(a)anthracene results in increased expression of GRAMD1A mRNA CTD PMID:26377693 NCBI chr 1:86,367,001...86,393,348 JBrowse link
G Gramd1c GRAM domain containing 1C decreases expression ISO benz(a)anthracene results in decreased expression of GRAMD1C mRNA CTD PMID:26377693 NCBI chr11:56,633,229...56,718,570 JBrowse link
G Grb10 growth factor receptor bound protein 10 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of GRB10 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRB10 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr14:90,708,653...90,816,399 JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of GREB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GREB1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 6:39,440,522...39,562,364 JBrowse link
G Grifin galectin-related inter-fiber protein multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRIFIN mRNA CTD PMID:27858113 NCBI chr12:14,080,170...14,082,892 JBrowse link
G Grk3 G protein-coupled receptor kinase 3 increases expression ISO benz(a)anthracene results in increased expression of GRK3 mRNA CTD PMID:26377693 NCBI chr12:49,285,228...49,395,803 JBrowse link
G Grp gastrin releasing peptide multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA CTD PMID:27858113 NCBI chr18:59,388,679...59,402,061 JBrowse link
G Gsap gamma-secretase activating protein increases expression ISO benz(a)anthracene results in increased expression of GSAP mRNA CTD PMID:26377693 NCBI chr 4:13,813,046...13,907,875 JBrowse link
G Gsta1 glutathione S-transferase alpha 1 decreases expression ISO benz(a)anthracene results in decreased expression of GSTA1 mRNA CTD PMID:32890658 NCBI chr 9:23,703,476...23,720,121 JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions
increases activity
increases expression
EXP 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [benz(a)anthracene results in increased activity of GSTA2 protein]; Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of GSTA2 protein]; Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of GSTA2 mRNA]; Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of GSTA2 protein] CTD PMID:7587946 NCBI chr 8:79,184,535...79,196,827 JBrowse link
G Gtf3c2 general transcription factor IIIC subunit 2 increases expression ISO benz(a)anthracene results in increased expression of GTF3C2 mRNA CTD PMID:26377693 NCBI chr 6:25,196,439...25,221,338 JBrowse link
G Gtpbp2 GTP binding protein 2 increases expression ISO benz(a)anthracene results in increased expression of GTPBP2 mRNA CTD PMID:26377693 NCBI chr 9:14,813,964...14,823,419 JBrowse link
G Gzma granzyme A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GZMA mRNA CTD PMID:27858113 NCBI chr 2:44,740,569...44,752,502 JBrowse link
G H1f2 H1.2 linker histone, cluster member multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 NCBI chr17:41,818,962...41,820,453 JBrowse link
G H1f4 H1.4 linker histone, cluster member multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H1F4 mRNA CTD PMID:27858113 NCBI chr17:41,914,425...41,915,206 JBrowse link
G H2ax H2A.X variant histone increases expression ISO benz(a)anthracene metabolite results in increased expression of H2AX protein CTD PMID:31051210 NCBI chr 8:53,568,718...53,570,072 JBrowse link
G Haghl hydroxyacylglutathione hydrolase-like increases expression ISO benz(a)anthracene results in increased expression of HAGHL mRNA CTD PMID:26377693 NCBI chr10:14,804,957...14,809,495 JBrowse link
G Haus4 HAUS augmin-like complex, subunit 4 increases expression ISO benz(a)anthracene results in increased expression of HAUS4 mRNA CTD PMID:26377693 NCBI chr15:27,994,530...28,006,147 JBrowse link
G Haus5 HAUS augmin-like complex, subunit 5 increases expression ISO benz(a)anthracene results in increased expression of HAUS5 mRNA CTD PMID:26377693 NCBI chr 1:85,912,371...85,924,327 JBrowse link
G Hck HCK proto-oncogene, Src family tyrosine kinase increases expression ISO benz(a)anthracene results in increased expression of HCK mRNA CTD PMID:26377693 NCBI chr 3:162,031,833...162,074,933 JBrowse link
G Hdac10 histone deacetylase 10 increases expression ISO benz(a)anthracene results in increased expression of HDAC10 mRNA CTD PMID:26377693 NCBI chr 7:120,199,126...120,205,850 JBrowse link
G Heatr1 HEAT repeat containing 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HEATR1 mRNA CTD PMID:27858113 NCBI chr17:58,053,288...58,093,895 JBrowse link
G Helz2 helicase with zinc finger 2 decreases expression ISO benz(a)anthracene results in decreased expression of HELZ2 mRNA CTD PMID:26377693 NCBI chr 3:168,338,813...168,353,219 JBrowse link
G Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 increases expression ISO benz(a)anthracene results in increased expression of HERC1 mRNA CTD PMID:26377693 NCBI chr 8:75,796,347...75,965,347 JBrowse link
G Herc3 HECT and RLD domain containing E3 ubiquitin protein ligase 3 increases expression ISO benz(a)anthracene results in increased expression of HERC3 mRNA CTD PMID:26377693 NCBI chr 4:87,952,202...88,042,492 JBrowse link
G Hes2 hes family bHLH transcription factor 2 increases expression ISO benz(a)anthracene results in increased expression of HES2 mRNA CTD PMID:26377693 NCBI chr 5:167,947,948...167,964,660 JBrowse link
G Hic1 HIC ZBTB transcriptional repressor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HIC1 mRNA CTD PMID:27858113 NCBI chr10:60,512,855...60,517,812 JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 NCBI chr 4:58,836,463...58,839,423 JBrowse link
G Hkdc1 hexokinase domain containing 1 increases expression ISO benz(a)anthracene results in increased expression of HKDC1 mRNA CTD PMID:26377693 NCBI chr20:30,878,037...30,917,044 JBrowse link
G Hlf HLF transcription factor, PAR bZIP family member increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of HLF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HLF mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:75,651,320...75,708,979 JBrowse link
G Hm13 histocompatibility minor 13 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H13 mRNA CTD PMID:27858113 NCBI chr 3:141,145,792...141,183,557 JBrowse link
G Hmcn1 hemicentin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMCN1 mRNA CTD PMID:27858113 NCBI chr13:65,165,532...65,634,681 JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGB1 mRNA CTD PMID:27858113 NCBI chr12:11,009,236...11,015,941 JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 increases expression ISO benz(a)anthracene results in increased expression of HMGN2 mRNA CTD PMID:26377693 NCBI chr 5:146,192,126...146,195,580 JBrowse link
G Hmgn5 high mobility group nucleosome binding domain 5 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of HMGN5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGN5 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr  X:78,161,439...78,170,613 JBrowse link
G Hnmt histamine N-methyltransferase decreases expression ISO benz(a)anthracene results in decreased expression of HNMT mRNA CTD PMID:26377693 NCBI chr 3:6,591,804...6,623,821 JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 increases expression ISO benz(a)anthracene results in increased expression of HNRNPA2B1 mRNA CTD PMID:26377693 NCBI chr 4:81,867,354...81,875,886 JBrowse link
G Hnrnpc heterogeneous nuclear ribonucleoprotein C decreases expression ISO benz(a)anthracene results in decreased expression of HNRNPC mRNA CTD PMID:26377693 NCBI chr15:24,779,593...24,809,213 JBrowse link
G Hnrnpdl heterogeneous nuclear ribonucleoprotein D-like increases expression ISO benz(a)anthracene results in increased expression of HNRNPDL mRNA CTD PMID:26377693 NCBI chr14:9,861,716...9,867,945 JBrowse link
G Hnrnpf heterogeneous nuclear ribonucleoprotein F multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA CTD PMID:27858113 NCBI chr 4:152,755,668...152,776,867 JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 decreases expression ISO benz(a)anthracene results in decreased expression of HNRNPH1 mRNA CTD PMID:26377693 NCBI chr10:34,692,868...34,702,849 JBrowse link
G Hps1 HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HPS1 mRNA CTD PMID:27858113 NCBI chr 1:241,551,180...241,577,292 JBrowse link
G Hsd3b7 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 increases expression ISO benz(a)anthracene results in increased expression of HSD3B7 mRNA CTD PMID:26377693 NCBI chr 1:191,842,688...191,845,919 JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of HSPA1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HSPA1A mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr20:3,875,411...3,877,866 JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 decreases expression ISO benz(a)anthracene results in decreased expression of HSPA8 mRNA CTD PMID:26377693 NCBI chr 8:50,080,514...50,084,376 JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 decreases expression ISO benz(a)anthracene results in decreased expression of HSPD1 mRNA CTD PMID:26377693 NCBI chr 9:64,073,610...64,084,332 JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HTATIP2 mRNA CTD PMID:27858113 NCBI chr 1:108,609,424...108,624,810 JBrowse link
G Htatsf1 HIV-1 Tat specific factor 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of HTATSF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HTATSF1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr  X:134,935,426...134,949,607 JBrowse link
G Hunk hormonally upregulated Neu-associated kinase increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of HUNK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr11:43,127,244...43,244,502 JBrowse link
G Hyal1 hyaluronidase 1 decreases expression ISO benz(a)anthracene results in decreased expression of HYAL1 mRNA CTD PMID:26377693 NCBI chr 8:108,250,668...108,254,519 JBrowse link
G Ica1 islet cell autoantigen 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ICA1 mRNA CTD PMID:27858113 NCBI chr 4:36,656,475...36,804,705 JBrowse link
G Icoslg inducible T-cell co-stimulator ligand increases expression ISO benz(a)anthracene results in increased expression of ICOSL mRNA CTD PMID:26377693 NCBI chr20:10,600,420...10,610,718 JBrowse link
G Id1 inhibitor of DNA binding 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ID1 mRNA CTD PMID:27858113 NCBI chr 3:161,671,525...161,672,691 JBrowse link
G Idua alpha-L-iduronidase increases expression ISO benz(a)anthracene results in increased expression of IDUA mRNA CTD PMID:26377693 NCBI chr14:1,031,588...1,059,494 JBrowse link
G Ier3 immediate early response 3 increases expression ISO benz(a)anthracene results in increased expression of IER3 mRNA CTD PMID:22579512 NCBI chr20:2,933,173...2,934,377 JBrowse link
G Ier5 immediate early response 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IER5 mRNA CTD PMID:27858113 NCBI chr13:67,270,134...67,272,226 JBrowse link
G Iffo1 intermediate filament family orphan 1 increases expression ISO benz(a)anthracene results in increased expression of IFFO1 mRNA CTD PMID:26377693 NCBI chr 4:157,945,075...157,962,302 JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A decreases expression ISO benz(a)anthracene results in decreased expression of IFI27L2A mRNA CTD PMID:26377693 NCBI chr 6:122,598,872...122,600,358 JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO benz(a)anthracene results in decreased expression of IFI44 mRNA CTD PMID:26377693 NCBI chr 2:243,286,050...243,303,869 JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 decreases expression ISO benz(a)anthracene results in decreased expression of IFIT3 mRNA CTD PMID:26377693 NCBI chr 1:232,114,166...232,119,311 JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO benz(a)anthracene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 NCBI chr 9:74,452,371...74,464,953 JBrowse link
G Igflr1 IGF-like family receptor 1 affects expression ISO benz(a)anthracene affects the expression of IGFLR1 mRNA CTD PMID:26377693 NCBI chr 1:85,818,428...85,821,032 JBrowse link
G Igsf3 immunoglobulin superfamily, member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA CTD PMID:27858113 NCBI chr 2:188,811,394...188,899,645 JBrowse link
G Igsf6 immunoglobulin superfamily, member 6 increases expression ISO benz(a)anthracene results in increased expression of IGSF6 mRNA CTD PMID:26377693 NCBI chr 1:175,610,167...175,620,662 JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA CTD PMID:27858113 NCBI chr 7:1,063,283...1,102,940 JBrowse link
G Il18r1 interleukin 18 receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IL18R1 mRNA CTD PMID:27858113 NCBI chr 9:42,727,416...42,760,971 JBrowse link
G Il1a interleukin 1 alpha increases expression ISO benz(a)anthracene results in increased expression of IL1A mRNA CTD PMID:8156173 NCBI chr 3:136,979,804...136,990,236 JBrowse link
G Il1b interleukin 1 beta decreases expression ISO benz(a)anthracene results in decreased expression of IL1B mRNA CTD PMID:8156173 NCBI chr 3:137,030,200...137,036,581 JBrowse link
G Il4i1 interleukin 4 induced 1 increases expression ISO benz(a)anthracene results in increased expression of IL4I1 mRNA CTD PMID:26377693 NCBI chr 1:95,299,457...95,324,564 JBrowse link
G Il6 interleukin 6 increases secretion
multiple interactions
increases expression
ISO benz(a)anthracene results in increased secretion of IL6 protein
[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6 mRNA; [benz(a)anthracene co-treated with TNF protein] results in increased secretion of IL6 protein; AHR protein affects the reaction [[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6]; Curcumin inhibits the reaction [[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6 mRNA]; RELA protein affects the reaction [[benz(a)anthracene co-treated with TNF protein] results in increased expression of IL6]; Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of IL6 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased secretion of IL6 protein]
CTD PMID:8156173 PMID:22643241 PMID:23396138 PMID:25433334 NCBI chr 4:5,889,999...5,894,575 JBrowse link
G Il7r interleukin 7 receptor increases expression ISO benz(a)anthracene results in increased expression of IL7R mRNA CTD PMID:26377693 NCBI chr 2:58,452,393...58,477,757 JBrowse link
G Ilf2 interleukin enhancer binding factor 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA CTD PMID:27858113 NCBI chr 2:178,256,927...178,268,773 JBrowse link
G Ilrun inflammation and lipid regulator with UBA-like and NBR1-like domains decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ILRUN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILRUN mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr20:5,809,931...5,876,197 JBrowse link
G Inafm2 InaF motif containing 2 decreases expression ISO benz(a)anthracene results in decreased expression of INAFM2 mRNA CTD PMID:26377693 NCBI chr 3:105,728,208...105,733,766 JBrowse link
G Inka2 inka box actin regulator 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA CTD PMID:27858113 NCBI chr 2:193,185,275...193,200,643 JBrowse link
G Ino80b INO80 complex subunit B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of INO80B mRNA CTD PMID:27858113 NCBI chr 4:117,185,427...117,188,930 JBrowse link
G Inpp5k inositol polyphosphate-5-phosphatase K increases expression ISO benz(a)anthracene results in increased expression of INPP5K mRNA CTD PMID:26377693 NCBI chr10:60,474,262...60,495,813 JBrowse link
G Ints6l integrator complex subunit 6 like increases expression ISO benz(a)anthracene results in increased expression of INTS6L mRNA CTD PMID:26377693 NCBI chr  X:134,258,117...134,325,706 JBrowse link
G Iqce IQ motif containing E increases expression ISO benz(a)anthracene results in increased expression of IQCE mRNA CTD PMID:26377693 NCBI chr12:13,943,290...13,982,708 JBrowse link
G Iqsec3 IQ motif and Sec7 domain ArfGEF 3 increases expression ISO benz(a)anthracene results in increased expression of IQSEC3 mRNA CTD PMID:26377693 NCBI chr 4:154,610,933...154,707,310 JBrowse link
G Irag2 inositol 1,4,5-triphosphate receptor associated 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of IRAG2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IRAG2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:178,088,902...178,143,569 JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 decreases expression ISO benz(a)anthracene results in decreased expression of IRF2BP2 mRNA CTD PMID:26377693 NCBI chr19:54,559,417...54,565,096 JBrowse link
G Irf2bpl interferon regulatory factor 2 binding protein-like multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IRF2BPL mRNA CTD PMID:27858113 NCBI chr 6:112,258,149...112,262,264 JBrowse link
G Irf7 interferon regulatory factor 7 decreases expression ISO benz(a)anthracene results in decreased expression of IRF7 mRNA CTD PMID:26377693 NCBI chr 1:205,796,956...205,800,543 JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO benz(a)anthracene results in decreased expression of ISG15 mRNA CTD PMID:26377693 NCBI chr 5:172,066,369...172,067,656 JBrowse link
G Itga1 integrin subunit alpha 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA1 mRNA CTD PMID:27858113 NCBI chr 2:48,379,181...48,545,336 JBrowse link
G Itga2 integrin subunit alpha 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of ITGA2 mRNA
Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ITGA2 mRNA]; SB 203580 inhibits the reaction [benz(a)anthracene results in increased expression of ITGA2 mRNA]
CTD PMID:21635667 NCBI chr 2:46,520,345...46,621,487 JBrowse link
G Itga7 integrin subunit alpha 7 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA7 mRNA CTD PMID:27858113 NCBI chr 7:1,360,125...1,388,886 JBrowse link
G Itgb1 integrin subunit beta 1 decreases expression ISO benz(a)anthracene results in decreased expression of ITGB1 mRNA CTD PMID:26377693 NCBI chr19:73,602,277...73,650,271 JBrowse link
G Itih4 inter-alpha-trypsin inhibitor heavy chain 4 increases expression ISO benz(a)anthracene results in increased expression of ITIH4 mRNA CTD PMID:26377693 NCBI chr16:6,080,539...6,095,710 JBrowse link
G Itpripl2 ITPRIP like 2 decreases expression ISO benz(a)anthracene results in decreased expression of ITPRIPL2 mRNA CTD PMID:26377693 NCBI chr 1:172,801,152...172,803,047 JBrowse link
G Itsn1 intersectin 1 decreases expression ISO benz(a)anthracene results in decreased expression of ITSN1 mRNA CTD PMID:26377693 NCBI chr11:44,464,515...44,646,598 JBrowse link
G Izumo4 IZUMO family member 4 affects expression ISO benz(a)anthracene affects the expression of IZUMO4 mRNA CTD PMID:26377693 NCBI chr 7:9,007,276...9,010,428 JBrowse link
G Jade1 jade family PHD finger 1 decreases expression ISO benz(a)anthracene results in decreased expression of JADE1 mRNA CTD PMID:26377693 NCBI chr 2:124,543,233...124,596,361 JBrowse link
G Jak3 Janus kinase 3 increases expression ISO benz(a)anthracene results in increased expression of JAK3 mRNA CTD PMID:26377693 NCBI chr16:18,418,807...18,432,515 JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of JUN mRNA]; SB 203580 inhibits the reaction [benz(a)anthracene results in increased expression of JUN mRNA] CTD PMID:21635667 NCBI chr 5:115,009,900...115,012,993 JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KANK4 mRNA CTD PMID:27858113 NCBI chr 5:118,516,994...118,581,024 JBrowse link
G Kazn kazrin, periplakin interacting protein increases expression ISO benz(a)anthracene results in increased expression of KAZN mRNA CTD PMID:26377693 NCBI chr 5:159,675,803...160,666,084 JBrowse link
G Kcne3 potassium voltage-gated channel subfamily E regulatory subunit 3 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of KCNE3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KCNE3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:154,523,903...154,530,865 JBrowse link
G Kctd12b potassium channel tetramerization domain containing 12b increases expression ISO benz(a)anthracene results in increased expression of KCTD12B mRNA CTD PMID:26377693 NCBI chr  X:17,643,707...17,654,820 JBrowse link
G Kif21b kinesin family member 21B increases expression ISO benz(a)anthracene results in increased expression of KIF21B mRNA CTD PMID:26377693 NCBI chr13:47,576,129...47,626,112 JBrowse link
G Kif26b kinesin family member 26B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KIF26B mRNA CTD PMID:27858113 NCBI chr13:90,282,821...90,689,058 JBrowse link
G Kifc2 kinesin family member C2 affects expression ISO benz(a)anthracene affects the expression of KIFC2 mRNA CTD PMID:26377693 NCBI chr 7:108,380,634...108,388,364 JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase increases expression ISO benz(a)anthracene results in increased expression of KIT mRNA CTD PMID:26377693 NCBI chr14:32,901,615...32,978,895 JBrowse link
G Kitlg KIT ligand decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of KITL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 7:36,782,621...36,863,796 JBrowse link
G Klf12 KLF transcription factor 12 decreases expression ISO benz(a)anthracene results in decreased expression of KLF12 mRNA CTD PMID:26377693 NCBI chr15:83,037,548...83,469,998 JBrowse link
G Klf5 KLF transcription factor 5 decreases expression ISO benz(a)anthracene results in decreased expression of KLF5 mRNA CTD PMID:26377693 NCBI chr15:76,060,320...76,079,445 JBrowse link
G Klhdc8b kelch domain containing 8B affects expression ISO benz(a)anthracene affects the expression of KLHDC8B mRNA CTD PMID:26377693 NCBI chr 8:109,141,594...109,146,584 JBrowse link
G Klhdc9 kelch domain containing 9 increases expression ISO benz(a)anthracene results in increased expression of KLHDC9 mRNA CTD PMID:26377693 NCBI chr13:83,790,390...83,794,080 JBrowse link
G Klhl5 kelch-like family member 5 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL5 mRNA CTD PMID:27858113 NCBI chr14:43,497,915...43,565,833 JBrowse link
G Klhl6 kelch-like family member 6 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL6 mRNA CTD PMID:27858113 NCBI chr11:80,970,917...81,010,593 JBrowse link
G Klrd1 killer cell lectin like receptor D1 increases expression ISO benz(a)anthracene results in increased expression of KLRD1 mRNA CTD PMID:26377693 NCBI chr 4:163,044,920...163,056,568 JBrowse link
G Kmt2d lysine methyltransferase 2D multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT2D mRNA CTD PMID:27858113 NCBI chr 7:129,980,744...130,022,088 JBrowse link
G Kmt5a lysine methyltransferase 5A decreases expression ISO benz(a)anthracene results in decreased expression of KMT5A mRNA CTD PMID:26377693 NCBI chr12:37,800,339...37,823,706 JBrowse link
G Kmt5b lysine methyltransferase 5B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT5B mRNA CTD PMID:27858113 NCBI chr 1:210,429,672...210,479,042 JBrowse link
G Krba1 KRAB-A domain containing 1 increases expression ISO benz(a)anthracene results in increased expression of KRBA1 mRNA CTD PMID:26377693 NCBI chr 4:77,341,654...77,363,075 JBrowse link
G Krt15 keratin 15 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA CTD PMID:27858113 NCBI chr10:85,066,797...85,070,614 JBrowse link
G Krt31 keratin 31 increases expression ISO benz(a)anthracene results in increased expression of KRT31 mRNA CTD PMID:26377693 NCBI chr10:85,479,533...85,483,300 JBrowse link
G Krtcap3 keratinocyte associated protein 3 decreases expression ISO benz(a)anthracene results in decreased expression of KRTCAP3 mRNA CTD PMID:26377693 NCBI chr 6:25,120,938...25,122,522 JBrowse link
G Kyat1 kynurenine aminotransferase 1 decreases expression ISO benz(a)anthracene results in decreased expression of KYAT1 mRNA CTD PMID:26377693 NCBI chr 3:33,857,407...33,891,153 JBrowse link
G Lama1 laminin subunit alpha 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LAMA1 mRNA CTD PMID:27858113 NCBI chr 9:115,139,548...115,263,620 JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 NCBI chr10:83,290,820...83,331,989 JBrowse link
G Lca5l lebercilin LCA5 like increases expression ISO benz(a)anthracene results in increased expression of LCA5L mRNA CTD PMID:26377693 NCBI chr11:35,460,646...35,495,133 JBrowse link
G Lcorl ligand dependent nuclear receptor corepressor-like decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of LCORL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LCORL mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr14:69,482,919...69,620,269 JBrowse link
G Lefty1 left right determination factor 1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of LEFTY1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEFTY1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr13:92,649,226...92,659,722 JBrowse link
G Leng8 leukocyte receptor cluster member 8 increases expression ISO benz(a)anthracene results in increased expression of LENG8 mRNA CTD PMID:26377693 NCBI chr 1:79,113,038...79,124,868 JBrowse link
G Leo1 LEO1 homolog, Paf1/RNA polymerase II complex component decreases expression ISO benz(a)anthracene results in decreased expression of LEO1 mRNA CTD PMID:26377693 NCBI chr 8:76,199,547...76,223,983 JBrowse link
G Lepr leptin receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA CTD PMID:27858113 NCBI chr 5:121,409,735...121,593,201 JBrowse link
G Lgals1 galectin 1 increases expression ISO benz(a)anthracene results in increased expression of LGALS1 mRNA CTD PMID:22579512 NCBI chr 7:112,365,695...112,368,801 JBrowse link
G Lgals4 galectin 4 affects expression ISO benz(a)anthracene affects the expression of LGALS4 mRNA CTD PMID:26377693 NCBI chr 1:84,124,766...84,132,481 JBrowse link
G Lhfpl3 LHFPL tetraspan subfamily member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LHFPL3 mRNA CTD PMID:27858113
G Lime1 Lck interacting transmembrane adaptor 1 affects expression ISO benz(a)anthracene affects the expression of LIME1 mRNA CTD PMID:26377693 NCBI chr 3:168,490,535...168,496,627 JBrowse link
G Lipa lipase A, lysosomal acid type decreases expression ISO benz(a)anthracene results in decreased expression of LIPA mRNA CTD PMID:26377693 NCBI chr 1:241,437,524...241,470,936 JBrowse link
G Lpin1 lipin 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LPIN1 mRNA CTD PMID:27858113 NCBI chr 6:45,039,110...45,145,845 JBrowse link
G Lratd1 LRAT domain containing 1 decreases expression ISO benz(a)anthracene results in decreased expression of LRATD1 mRNA CTD PMID:26377693 NCBI chr 6:36,916,969...36,922,143 JBrowse link
G Lrp12 LDL receptor related protein 12 increases expression ISO benz(a)anthracene results in increased expression of LRP12 mRNA CTD PMID:26377693 NCBI chr 7:70,941,068...71,012,409 JBrowse link
G Lrrc36 leucine rich repeat containing 36 increases expression ISO benz(a)anthracene results in increased expression of LRRC36 mRNA CTD PMID:26377693 NCBI chr19:33,292,074...33,342,426 JBrowse link
G Lrrc45 leucine rich repeat containing 45 affects expression ISO benz(a)anthracene affects the expression of LRRC45 mRNA CTD PMID:26377693 NCBI chr10:106,492,846...106,500,751 JBrowse link
G Lrrc71 leucine rich repeat containing 71 increases expression ISO benz(a)anthracene results in increased expression of LRRC71 mRNA CTD PMID:26377693 NCBI chr 2:173,194,792...173,207,448 JBrowse link
G Lrrc75b leucine rich repeat containing 75B multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRRC75B mRNA CTD PMID:27858113 NCBI chr20:13,100,302...13,106,503 JBrowse link
G Lrrk1 leucine-rich repeat kinase 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of LRRK1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LRRK1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:129,254,815...129,390,217 JBrowse link
G Lrrn4 leucine rich repeat neuronal 4 decreases expression ISO benz(a)anthracene results in decreased expression of LRRN4 mRNA CTD PMID:26377693 NCBI chr 3:120,138,093...120,150,877 JBrowse link
G Lrtm2 leucine-rich repeats and transmembrane domains 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of LRTM2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRTM2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 4:152,485,863...152,508,248 JBrowse link
G Lsm14b LSM family member 14B increases expression ISO benz(a)anthracene results in increased expression of LSM14B mRNA CTD PMID:26377693 NCBI chr 3:167,125,633...167,136,417 JBrowse link
G Lst1 leukocyte specific transcript 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LST1 mRNA CTD PMID:27858113 NCBI chr20:3,634,680...3,639,731 JBrowse link
G Ltc4s leukotriene C4 synthase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LTC4S mRNA CTD PMID:27858113 NCBI chr10:35,060,002...35,066,466 JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor decreases expression ISO benz(a)anthracene results in decreased expression of LUC7L3 mRNA CTD PMID:26377693 NCBI chr10:79,737,457...79,773,478 JBrowse link
G Lum lumican multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LUM mRNA CTD PMID:27858113 NCBI chr 7:34,245,323...34,252,510 JBrowse link
G Ly6a lymphocyte antigen 6 family member A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LY6A mRNA CTD PMID:27858113 NCBI chr 7:107,177,191...107,189,436 JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LYVE1 mRNA CTD PMID:27858113 NCBI chr 1:164,962,872...164,976,309 JBrowse link
G Lyzl4 lysozyme-like 4 increases expression ISO benz(a)anthracene results in increased expression of LYZL4 mRNA CTD PMID:26377693 NCBI chr 8:121,248,129...121,255,366 JBrowse link
G Lztr1 leucine zipper like post translational regulator 1 increases expression ISO benz(a)anthracene results in increased expression of LZTR1 mRNA CTD PMID:26377693 NCBI chr11:83,487,717...83,503,896 JBrowse link
G Lzts3 leucine zipper tumor suppressor family member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LZTS3 mRNA CTD PMID:27858113 NCBI chr 3:117,850,286...117,861,132 JBrowse link
G Mageh1 MAGE family member H1 increases expression ISO benz(a)anthracene results in increased expression of MAGEH1 mRNA CTD PMID:26377693 NCBI chr  X:18,350,015...18,351,271 JBrowse link
G Magi3 membrane associated guanylate kinase, WW and PDZ domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA CTD PMID:27858113 NCBI chr 2:191,514,726...191,717,048 JBrowse link
G Magt1 magnesium transporter 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MAGT1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGT1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr  X:75,104,040...75,145,247 JBrowse link
G Malt1 MALT1 paracaspase increases expression ISO benz(a)anthracene results in increased expression of MALT1 mRNA CTD PMID:26377693 NCBI chr18:61,212,290...61,266,272 JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor decreases expression ISO benz(a)anthracene results in decreased expression of MANF mRNA CTD PMID:26377693 NCBI chr 8:107,500,856...107,551,595 JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAOA mRNA CTD PMID:27858113 NCBI chr  X:8,615,239...8,681,372 JBrowse link
G Map3k14 mitogen-activated protein kinase kinase kinase 14 increases expression ISO benz(a)anthracene results in increased expression of MAP3K14 mRNA CTD PMID:26377693 NCBI chr10:88,665,417...88,715,669 JBrowse link
G Map4k2 mitogen activated protein kinase kinase kinase kinase 2 increases expression ISO benz(a)anthracene results in increased expression of MAP4K2 mRNA CTD PMID:26377693 NCBI chr 1:213,074,360...213,090,042 JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 NCBI chr 9:49,696,573...49,822,353 JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions
increases phosphorylation
ISO Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein] CTD PMID:21635667 NCBI chr20:6,751,288...6,812,294 JBrowse link
G Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3 affects expression ISO benz(a)anthracene affects the expression of MAPK8IP3 mRNA CTD PMID:26377693 NCBI chr10:13,918,417...13,958,335 JBrowse link
G Marchf1 membrane associated ring-CH-type finger 1 increases expression ISO benz(a)anthracene results in increased expression of MARCHF1 mRNA CTD PMID:26377693 NCBI chr16:23,255,551...24,114,290 JBrowse link
G Marco macrophage receptor with collagenous structure multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MARCO mRNA CTD PMID:27858113 NCBI chr13:31,616,278...31,648,521 JBrowse link
G Marveld3 MARVEL domain containing 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MARVELD3 mRNA CTD PMID:27858113 NCBI chr19:37,908,727...37,923,420 JBrowse link
G Mat1a methionine adenosyltransferase 1A multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAT1A mRNA CTD PMID:27858113 NCBI chr16:16,983,084...17,001,284 JBrowse link
G Mat2a methionine adenosyltransferase 2A decreases expression ISO benz(a)anthracene results in decreased expression of MAT2A mRNA CTD PMID:26377693 NCBI chr 4:106,048,043...106,053,612 JBrowse link
G Mbip MAP3K12 binding inhibitory protein 1 increases expression ISO benz(a)anthracene results in increased expression of MBIP mRNA CTD PMID:26377693 NCBI chr 6:73,808,133...73,825,394 JBrowse link
G Mboat2 membrane bound O-acyltransferase domain containing 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MBOAT2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 6:41,471,135...41,597,599 JBrowse link
G Mcam melanoma cell adhesion molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MCAM mRNA CTD PMID:27858113 NCBI chr 8:44,479,391...44,487,575 JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression ISO benz(a)anthracene results in increased expression of MCM6 mRNA CTD PMID:26377693 NCBI chr13:42,379,161...42,404,352 JBrowse link
G Mcoln3 mucolipin TRP cation channel 3 increases expression ISO benz(a)anthracene results in increased expression of MCOLN3 mRNA CTD PMID:26377693 NCBI chr 2:235,008,716...235,042,885 JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA CTD PMID:27858113 NCBI chr 7:55,176,558...55,201,757 JBrowse link
G Mdm4 MDM4 regulator of p53 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MDM4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDM4 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr13:46,922,236...47,068,241 JBrowse link
G Mdn1 midasin AAA ATPase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA CTD PMID:27858113 NCBI chr 5:51,851,785...51,982,688 JBrowse link
G Mecom MDS1 and EVI1 complex locus decreases expression ISO benz(a)anthracene results in decreased expression of MECOM mRNA CTD PMID:26377693 NCBI chr 2:114,837,815...115,393,052 JBrowse link
G Meg3 maternally expressed 3 affects expression ISO benz(a)anthracene affects the expression of MEG3 mRNA CTD PMID:26377693 NCBI chr 6:128,491,808...128,524,010 JBrowse link
G Megf6 multiple EGF-like-domains 6 increases expression ISO benz(a)anthracene results in increased expression of MEGF6 mRNA CTD PMID:26377693 NCBI chr 5:170,020,699...170,121,557 JBrowse link
G Meiob meiosis specific with OB-fold decreases expression ISO benz(a)anthracene results in decreased expression of MEIOB mRNA CTD PMID:26377693 NCBI chr10:13,833,170...13,865,684 JBrowse link
G Mesp1 mesoderm posterior bHLH transcription factor 1 increases expression ISO benz(a)anthracene results in increased expression of MESP1 mRNA CTD PMID:26377693 NCBI chr 1:143,147,671...143,149,189 JBrowse link
G Mettl18 methyltransferase 18, RPL3 N3(tau)-histidine increases expression ISO benz(a)anthracene results in increased expression of METTL18 mRNA CTD PMID:26377693 NCBI chr13:76,345,888...76,348,798 JBrowse link
G Mfap2 microfibril associated protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 NCBI chr 5:153,312,068...153,320,266 JBrowse link
G Mfap4 microfibril associated protein 4 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MFAP4 mRNA CTD PMID:27858113 NCBI chr10:46,666,552...46,669,613 JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid increases expression ISO benz(a)anthracene results in increased expression of MFSD2A mRNA CTD PMID:26377693 NCBI chr 5:140,510,933...140,525,828 JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MGAT2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGAT2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 6:87,656,360...87,658,849 JBrowse link
G Mgll monoglyceride lipase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA CTD PMID:27858113 NCBI chr 4:122,749,436...122,851,440 JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MGMT mRNA CTD PMID:27858113 NCBI chr 1:201,140,832...201,367,481 JBrowse link
G Mia3 MIA SH3 domain ER export factor 3 decreases expression ISO benz(a)anthracene results in decreased expression of MIA3 mRNA CTD PMID:26377693 NCBI chr13:94,970,421...95,012,071 JBrowse link
G Mical1 microtubule associated monooxygenase, calponin and LIM domain containing 1 increases expression ISO benz(a)anthracene results in increased expression of MICAL1 mRNA CTD PMID:26377693 NCBI chr20:46,547,983...46,568,487 JBrowse link
G Mideas mitotic deacetylase associated SANT domain protein multiple interactions
decreases expression
ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA
benz(a)anthracene results in decreased expression of MIDEAS mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 6:103,784,779...103,854,470 JBrowse link
G Mir181d microRNA 181d increases expression ISO benz(a)anthracene results in increased expression of MIR181D mRNA CTD PMID:23993976 NCBI chr19:23,983,706...23,983,788 JBrowse link
G Mir200c microRNA 200c increases expression ISO benz(a)anthracene results in increased expression of MIR200C mRNA CTD PMID:23993976 NCBI chr 4:157,523,679...157,523,747 JBrowse link
G Mir22 microRNA 22 increases expression ISO benz(a)anthracene results in increased expression of MIR22 mRNA CTD PMID:23993976 NCBI chr10:60,307,039...60,307,133 JBrowse link
G Mir221 microRNA 221 increases expression ISO benz(a)anthracene results in increased expression of MIR221 mRNA CTD PMID:23993976 NCBI chr  X:6,023,182...6,023,290 JBrowse link
G Mir23b microRNA 23b increases expression ISO benz(a)anthracene results in increased expression of MIR23B mRNA CTD PMID:23993976 NCBI chr17:1,813,667...1,813,763 JBrowse link
G Mir33 microRNA 33 decreases expression ISO benz(a)anthracene results in decreased expression of MIR33A mRNA CTD PMID:23993976 NCBI chr 7:115,593,952...115,594,020 JBrowse link
G Mirlet7b microRNA let-7b increases expression ISO benz(a)anthracene results in increased expression of MIRLET7B mRNA CTD PMID:23993976 NCBI chr 7:116,804,186...116,804,270 JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions ISO [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 PMID:38237855 NCBI chr 1:199,926,150...199,952,847 JBrowse link
G Mkks MKKS centrosomal shuttling protein decreases expression ISO benz(a)anthracene results in decreased expression of MKKS mRNA CTD PMID:26377693 NCBI chr 3:144,654,563...144,672,831 JBrowse link
G Mlph melanophilin increases expression ISO benz(a)anthracene results in increased expression of MLPH mRNA CTD PMID:26377693 NCBI chr 9:98,955,036...98,990,566 JBrowse link
G Mmd2 monocyte to macrophage differentiation-associated 2 decreases expression ISO benz(a)anthracene results in decreased expression of MMD2 mRNA CTD PMID:26377693 NCBI chr12:17,075,870...17,123,255 JBrowse link
G Mmp14 matrix metallopeptidase 14 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MMP14 mRNA CTD PMID:27858113 NCBI chr15:27,887,795...27,897,020 JBrowse link
G Mmp2 matrix metallopeptidase 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of MMP2 mRNA
Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of MMP2 mRNA]; SB 203580 inhibits the reaction [benz(a)anthracene results in increased expression of MMP2 mRNA]
CTD PMID:21635667 NCBI chr19:30,327,643...30,355,856 JBrowse link
G Mmp8 matrix metallopeptidase 8 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of MMP8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMP8 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 8:4,724,009...4,733,864 JBrowse link
G Mmrn2 multimerin 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMRN2 mRNA CTD PMID:27858113 NCBI chr16:9,705,925...9,727,405 JBrowse link
G Mnda myeloid cell nuclear differentiation antigen decreases expression ISO benz(a)anthracene results in decreased expression of MNDA mRNA CTD PMID:26377693 NCBI chr13:86,017,888...86,035,556 JBrowse link
G Morc4 MORC family CW-type zinc finger 4 decreases expression ISO benz(a)anthracene results in decreased expression of MORC4 mRNA CTD PMID:26377693 NCBI chr  X:103,477,366...103,529,026 JBrowse link
G Mpeg1 macrophage expressed 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MPEG1 mRNA CTD PMID:27858113 NCBI chr 1:209,452,176...209,456,692 JBrowse link
G Mphosph10 M-phase phosphoprotein 10 decreases expression ISO benz(a)anthracene results in decreased expression of MPHOSPH10 mRNA CTD PMID:26377693 NCBI chr 1:117,948,134...117,964,149 JBrowse link
G Mrln myoregulin decreases expression ISO benz(a)anthracene results in decreased expression of MRLN mRNA CTD PMID:26377693 NCBI chr20:18,406,789...18,423,805 JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 decreases expression ISO benz(a)anthracene results in decreased expression of MRPS6 mRNA CTD PMID:26377693 NCBI chr11:31,295,358...31,348,483 JBrowse link
G Ms4a1 membrane spanning 4-domains A1 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of MS4A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MS4A1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:207,906,370...207,927,028 JBrowse link
G Ms4a4a membrane spanning 4-domains A4A increases expression ISO benz(a)anthracene results in increased expression of MS4A4A mRNA CTD PMID:26377693 NCBI chr 1:208,060,507...208,085,121 JBrowse link
G Ms4a8 membrane spanning 4-domains A8 increases expression ISO benz(a)anthracene results in increased expression of MS4A8A mRNA CTD PMID:26377693 NCBI chr 1:207,730,665...207,744,260 JBrowse link
G Msln mesothelin decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MSLN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MSLN mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr10:14,771,946...14,781,382 JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MSR1 mRNA CTD PMID:27858113 NCBI chr16:52,717,775...52,803,602 JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I decreases expression ISO benz(a)anthracene results in decreased expression of COX1 mRNA CTD PMID:26377693
G Mt-nd4l mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND4L mRNA CTD PMID:27858113 NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
NCBI chr MT:9,870...10,166
JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of ND6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND6 mRNA
CTD PMID:26377693 PMID:27858113
G Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of MTHFD1L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTHFD1L mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:40,443,926...40,632,911 JBrowse link
G Mtmr10 myotubularin related protein 10 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTMR10 mRNA CTD PMID:27858113 NCBI chr 1:117,859,355...117,910,839 JBrowse link
G Mtx3 metaxin 3 decreases expression ISO benz(a)anthracene results in decreased expression of MTX3 mRNA CTD PMID:26377693 NCBI chr 2:24,066,332...24,079,708 JBrowse link
G Muc4 mucin 4, cell surface associated increases expression ISO benz(a)anthracene results in increased expression of MUC4 mRNA CTD PMID:26377693 NCBI chr11:68,008,245...68,053,242 JBrowse link
G Mx2 MX dynamin like GTPase 2 decreases expression ISO benz(a)anthracene results in decreased expression of MX2 mRNA CTD PMID:26377693 NCBI chr11:50,375,101...50,399,373 JBrowse link
G Myadm myeloid-associated differentiation marker decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of MYADM mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MYADM mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 1:65,864,180...65,874,701 JBrowse link
G Myo1g myosin IG increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of MYO1G mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr14:81,386,701...81,401,843 JBrowse link
G Myom3 myomesin 3 decreases expression ISO benz(a)anthracene results in decreased expression of MYOM3 mRNA CTD PMID:26377693 NCBI chr 5:147,992,737...148,043,282 JBrowse link
G Nap1l4 nucleosome assembly protein 1-like 4 decreases expression ISO benz(a)anthracene results in decreased expression of NAP1L4 mRNA CTD PMID:26377693 NCBI chr 1:198,709,697...198,746,093 JBrowse link
G Nat8 N-acetyltransferase 8 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NAT8 mRNA CTD PMID:27858113 NCBI chr 4:118,279,521...118,284,671 JBrowse link
G Nat8b N-acetyltransferase 8B decreases expression ISO benz(a)anthracene results in decreased expression of NAT8B mRNA CTD PMID:26377693 NCBI chr 4:118,359,445...118,364,351 JBrowse link
G Nbeal1 neurobeachin-like 1 decreases expression ISO benz(a)anthracene results in decreased expression of NBEAL1 mRNA CTD PMID:26377693 NCBI chr 9:69,069,326...69,237,932 JBrowse link
G Ncaph non-SMC condensin I complex, subunit H multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NCAPH mRNA CTD PMID:27858113 NCBI chr 3:134,825,271...134,852,502 JBrowse link
G Ncbp2 nuclear cap binding protein subunit 2 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of NCBP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr11:68,821,026...68,829,863 JBrowse link
G Ncbp3 nuclear cap binding subunit 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP3 mRNA CTD PMID:27858113 NCBI chr10:57,665,716...57,695,432 JBrowse link
G Nceh1 neutral cholesterol ester hydrolase 1 increases expression ISO benz(a)anthracene results in increased expression of NCEH1 mRNA CTD PMID:26377693 NCBI chr 2:112,003,677...112,064,274 JBrowse link
G Ndc80 NDC80 kinetochore complex component decreases expression ISO benz(a)anthracene results in decreased expression of NDC80 mRNA CTD PMID:22579512 NCBI chr 9:118,853,806...118,887,582 JBrowse link
G Ndor1 NADPH dependent diflavin oxidoreductase 1 decreases expression ISO benz(a)anthracene results in decreased expression of NDOR1 mRNA CTD PMID:26377693 NCBI chr 3:28,460,787...28,469,018 JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 affects expression ISO benz(a)anthracene affects the expression of NEAT1 mRNA CTD PMID:26377693 NCBI chr 1:203,129,229...203,140,014 JBrowse link
G Neb nebulin decreases expression ISO benz(a)anthracene results in decreased expression of NEB mRNA CTD PMID:26377693 NCBI chr 3:36,613,677...36,811,618 JBrowse link
G Necab1 N-terminal EF-hand calcium binding protein 1 decreases expression ISO benz(a)anthracene results in decreased expression of NECAB1 mRNA CTD PMID:26377693 NCBI chr 5:28,357,859...28,578,642 JBrowse link
G Nectin1 nectin cell adhesion molecule 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PVRL1 mRNA CTD PMID:27858113 NCBI chr 8:44,101,776...44,164,863 JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated 9 multiple interactions ISO [benz(a)anthracene co-treated with TNF protein] results in increased expression of NEDD9 mRNA CTD PMID:23396138 NCBI chr17:23,289,793...23,468,026 JBrowse link
G Nemp2 nuclear envelope integral membrane protein 2 increases expression ISO benz(a)anthracene results in increased expression of NEMP2 mRNA CTD PMID:26377693 NCBI chr 9:48,861,252...48,880,565 JBrowse link
G Neu2 neuraminidase 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NEU2 mRNA CTD PMID:27858113 NCBI chr 9:95,666,338...95,715,209 JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA CTD PMID:27858113 NCBI chr18:76,321,386...76,430,997 JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NFE2 mRNA CTD PMID:27858113 NCBI chr 7:134,382,758...134,395,364 JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of NFIL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFIL3 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr17:12,432,376...12,447,605 JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [benz(a)anthracene co-treated with TNF protein] results in increased phosphorylation of and results in increased degradation of NFKBIA protein CTD PMID:23396138 NCBI chr 6:78,593,844...78,597,307 JBrowse link
G Nfkbid NFKB inhibitor delta increases expression ISO benz(a)anthracene results in increased expression of NFKBID mRNA CTD PMID:26377693 NCBI chr 1:85,679,353...85,690,415 JBrowse link
G Nfrkb nuclear factor related to kappa B binding protein increases expression ISO benz(a)anthracene results in increased expression of NFRKB mRNA CTD PMID:26377693 NCBI chr 8:38,089,574...38,121,506 JBrowse link
G Ngfr nerve growth factor receptor multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFRSF10B mRNA CTD PMID:27858113 NCBI chr10:81,012,077...81,030,305 JBrowse link
G Nhej1 nonhomologous end-joining factor 1 decreases expression ISO benz(a)anthracene results in decreased expression of NHEJ1 mRNA CTD PMID:26377693 NCBI chr 9:76,526,322...76,622,488 JBrowse link
G Nherf1 NHERF family PDZ scaffold protein 1 increases expression ISO benz(a)anthracene results in increased expression of NHERF1 mRNA CTD PMID:26377693 NCBI chr10:100,403,189...100,420,290 JBrowse link
G Nhlrc2 NHL repeat containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NHLRC2 mRNA CTD PMID:27858113 NCBI chr 1:265,594,915...265,655,647 JBrowse link
G Nktr natural killer cell triggering receptor affects expression
multiple interactions
ISO benz(a)anthracene affects the expression of NKTR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NKTR mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 8:121,380,010...121,420,495 JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 decreases expression ISO benz(a)anthracene results in decreased expression of NLRC5 mRNA CTD PMID:26377693 NCBI chr19:10,477,638...10,581,023 JBrowse link
G Nostrin nitric oxide synthase trafficking decreases expression ISO benz(a)anthracene results in decreased expression of NOSTRIN mRNA CTD PMID:26377693 NCBI chr 3:53,904,746...53,970,995 JBrowse link
G Notch1 notch receptor 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NOTCH1 mRNA CTD PMID:27858113 NCBI chr 3:29,676,040...29,721,613 JBrowse link
G Noxo1 NADPH oxidase organizer 1 increases expression ISO benz(a)anthracene results in increased expression of NOXO1 mRNA CTD PMID:26377693 NCBI chr10:13,723,253...13,726,008 JBrowse link
G Nphp1 nephrocystin 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of NPHP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NPHP1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr 3:135,413,927...135,469,505 JBrowse link
G Npr3 natriuretic peptide receptor 3 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPR3 mRNA CTD PMID:27858113 NCBI chr 2:60,865,483...60,933,432 JBrowse link
G Npy1r neuropeptide Y receptor Y1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 NCBI chr16:27,804,416...27,814,070 JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression
multiple interactions
ISO
EXP
benz(a)anthracene results in increased activity of NQO1 protein
benz(a)anthracene results in increased expression of NQO1 mRNA
1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein]; Dexamethasone inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein]; Dexamethasone inhibits the reaction [benz(a)anthracene results in increased expression of NQO1 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein]]; Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein]
CTD PMID:7587946 PMID:9029048 PMID:17253728 NCBI chr19:52,205,374...52,220,267 JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D1 mRNA CTD PMID:27858113 NCBI chr10:84,224,599...84,231,812 JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 increases expression
multiple interactions
ISO benz(a)anthracene results in increased expression of NR1D2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D2 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr15:7,524,257...7,550,553 JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions EXP NR3C1 protein promotes the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]] CTD PMID:2916850 NCBI chr18:31,522,783...31,644,508 JBrowse link
G Nrbp2 nuclear receptor binding protein 2 decreases expression ISO benz(a)anthracene results in decreased expression of NRBP2 mRNA CTD PMID:26377693 NCBI chr 7:109,679,330...109,685,656 JBrowse link
G Nrcam neuronal cell adhesion molecule multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NRCAM mRNA CTD PMID:27858113 NCBI chr 6:61,402,813...61,698,536 JBrowse link
G Nrg4 neuregulin 4 increases expression ISO benz(a)anthracene results in increased expression of NRG4 mRNA CTD PMID:26377693 NCBI chr 8:55,586,253...55,677,829 JBrowse link
G Nsd1 nuclear receptor binding SET domain protein 1 decreases expression
multiple interactions
ISO benz(a)anthracene results in decreased expression of NSD1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NSD1 mRNA
CTD PMID:26377693 PMID:27858113 NCBI chr17:9,311,963...9,426,373 JBrowse link
G Nsg2 neuronal vesicle trafficking associated 2 increases expression ISO benz(a)anthracene results in increased expression of NSG2 mRNA CTD PMID:26377693 NCBI chr10:15,601,594...15,661,441 JBrowse link
G Nsmaf neutral sphingomyelinase activation associated factor increases expression ISO benz(a)anthracene results in increased expression of NSMAF mRNA CTD PMID:26377693 NCBI chr 5:24,315,319...24,378,346 JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 multiple interactions ISO [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA CTD PMID:27858113 NCBI chr16:6,3